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ABSTRACT 
This thesis reports the synthesis of new near infrared dyes in three chapters. The first 
two chapters outline the synthetic procedure for synthesizing mono- and pentamethine cyanine 
dyes. The initial chapter encompasses the synthesis of asymmetric monomethine dyes with red-
shifted optical properties. The second chapter involves the synthesis and assessment of new 
symmetrical quinolin-4-yl and phenanthridin-6-yl pentamethine dyes as potential oxidative DNA 
cleavage agents. The last chapter of the thesis details the synthesis and evaluation of new phe-
noxizinum dyes as contrast agents for insulunomia, a pancreatic cancer. Furthermore, all new 
compounds were characterized via NMR and their coherent optical properties were obtained. 
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1 Cyanine Dyes 
The proceeding chapter will focus on exploring the modifications to the general scaffold and the 
corresponding changes in optical properties and/or biological activity. 
1.1 Introduction to Cyanine Dyes 
Polymethine dyes and their derivatives such as carbocyanines, represent a class of organic 
molecules with absorption bands that covers a broad spectral range (400-1300 nm); larger than 
any other class of dye system1,2. A carbocyanine dye consists of two terminal aza-heterocycles 
connected via an electron deficient polymethine chain, as shown in Figure 1.  
 
Figure 1 Generic structure of cyanine dyes, polymethine core highlighted in red. 
 
The common name of cyanine dyes bearing the general structure, are derived by the number of 
n groups of the methine chain. For illustration, if n = 1, 2, 3, then the common names would be 
tri-, penta- and heptamethine cyanines, respectively, which indicate the number of methine unit 
(=C-H) between the aza-heterocycles. Due to the diversity in function associated with this class 
of chromophore, an extensive number of cyanine dyes have been synthesized for numerous 
applications in photographic processes and more recently as fluorescent probes for bio-
molecular labeling and imaging2-4. The applications of these dyes arise from the electron defi-
cient π -conjugated system between the heteroatom that allow for cyanine dyes to achieve 
model photo-physical properties such as good molar absorption coefficients (>105 M−1 cm−1), 
tunable fluorescence intensities, and narrow absorption bands. One may modify the absorption 
band of cyanine dye by altering the conjugated system via the length of the polymethine chain, 
varying the heterocyclic ring(s), and substituents on either the heteroatoms and/or ring. As 
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many compositions of dyes can be made, it is noteworthy that to make cyanine dyes be both 
non-toxic and stable towards chemical decomposition based on the applications of the dye. For 
example, polar groups are added, such as sulfonates or carboxylates as substituents on the dye 
system to achieve to biocompatibility, as seen in the only FDA approved cyanine dye indocya-
nine green (ICG) in Figure 1. 
 
Figure 1 FDA approved cyanine dye, Indocyanine green (ICG)  
To the same degree, specific structural modifications allow for cyanine dyes to assume proper-
ties that would enable it to target selectively and maintain the selected fluorescence and/or ab-
sorption bands. This chapter will discuss the cyanine chromophore syntheses and relevance in 
future applications.  
1.2  Synthesis of Monomethine Cyanine Dye  
Monomethine cyanine dyes, in which there is only one methine unit (=CH-) between the two 
terminal heterocycles, commonly absorb between 480-515 nm 5,6. In general, monomethines 
are prepared through the condensation of two heterocyclic quaternary salts with a basic rea-
gent. The requisites for the reactants includes: 1) one contain an active methyl group (promptly 
activated under the basic conditions) and 2) the other must possess a moiety that promotes the 
condensation reaction through an electrophilic site (electrophilic carbon attached to a good leav-
ing group), as shown in Equation 1. Common moieties include: thioether, imino, sulfobetaines, 
halide, ketone or more recently, a thioketone moiety, as shown in Scheme 17-9.  
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Equation 1 General synthesis of asymmetric and symmetric monomethine dyes; Y = Anion; het  = aza-heterocylce; 
LG  = Leaving Group =  -Cl, -SCH3, or - SO3-  
 
 
Scheme 1 Synthesis of asymmetric monomethine cyanine via utilizing ketones and thioketone intermediate  
 
A quaternary salt with an active methyl, such as N-methyl-2-methylbenzothiazole salt 1, can be 
condensed with a thione or ketone in basic solutions to afford asymmetric monomethine dyes 2 
and 3, as shown in Scheme 1. In a similar manner, symmetrical monomethine dyes can be af-
ford by utilizing either 3-methyl-2-iminobenzothiazolines or 3-methylbenzothiazoles-2-sulfonate 
salts, as other salt for the preparation of the dye 4 with salt 1, as shown in Scheme 16,7,10. Thus, 
monomethine dyes can be synthesized in both symmetrical and asymmetrical manners. Two 
asymmetrical dyes shown in Figure 2, Thaizole Orange (TO) and Oxazole Yellow (YO), are well 
known imagining probes in the biological sciences due to their enhanced photophysical proper-
ties upon binding to target macromolecule (i.e.nucleic acid structure protein, .etc.). These com-
pounds, TO and YO can be prepared via a thioether pathway as shown in Equation 211-13.  
 
Figure 2 Structures of Thaizole Orange (TO) and Oxazole Yellow (YO); X = Anion 
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Equation 2 Synthesis of asymmetric monomethine cyanines. TO and YO via a thioether intermediate 
 
The second chapter will utilize the thioether method for the synthesis of red-shifted monome-
thine dyes. 
1.3 Synthesis of Polymethine Dyes 
The synthetic preparation of polymethine dyes can be classified based on the intermediate used 
for the condensation. For example, trimethine dyes can be synthesized via three different meth-
ods, yielding symmetrical or asymmetrical trimethine dyes. The classical ortho ester method, 
established by Koenig et al., involves condensation of a quaternary salt with triethyl ortho for-
mate under basic conditions in acetic anhydride to afford symmetrical trimethine 8, as shown in 
Equation 3 14.  
 
Equation 3 condensation of a methyl-heterocycle with triethyl orthoformate in acetic anhydride to afford symmetrical 
trimethine  
 
Applying this method, our lab has synthesized a series of halogenated trimethine dyes as poten-
tial probes for G-quadruplex detection in vivo15. The dye system can also be modified to im-
prove photostability and spectral properties, such as the introduction of a CN group onto the tri-
methine chain of cyanine dye 12 via an aldehyde pathway, as shown in Equation 416. 
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Equation 4 Asymmetrical trimethine dyes via an aldehyde pathway
16
 
 
Trimethine dyes can also be synthesized in either both symmetrical and asymmetrical via the 
aldehyde pathway as shown in Scheme 2 17.  
 
Scheme 2 Synthesis of triemthine via aldehyde method 
 
This aldehyde method can also be applied to yield asymmetrical pentamethine dyes as shown 
in Scheme 318. 
 
Scheme 3 Asymmetrical pentamethine dyes via an aldehyde intermediate 
 
Lastly, tri-, penta-, and heptamethine cyanine syntheses can be achieved via the condensation 
reaction between a quaternary salt and methine-chain precursor 16, as shown in Scheme 418-20.  
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Scheme 4 Pathway for syntheses of polymethine via hemicyanine intermediate 
 
This method can applied to synthesize either symmetrical 17 or unsymmetrical 19 dyes by con-
trolling the ratio of the indole salt to polymethine chain linker 16, (N-diphenylformamidine, malo-
naldehyde dianil hydrochloride or glutacondianil hydrochloride for tri-, penta-, and heptamethine 
carbocyanines respectively). For unsymmetrical carbocyanine dyes, the reaction is proceed with 
a quaternary ammonium salt with linker in a 1:1 ratio, yielding the hemicyanine 18, which is iso-
lated and then reacted with another quaternary salt to afford dye 19. Symmetrical cyanine dyes, 
the reaction of quaternary ammonium salt with linker at a 2:1 ratio is carried out. Employing the 
hemicyanine method, the Henary group has synthesized  sets of symmetrical pentamthine dyes 
compounds as potent and selective PRMT inhibitors and oxidatively cleave U19 plasmid 
DNA19,21 Furthermore, our lab has also applied this method to afford penta- and heptamethine 
as novel NIR contrast agents, which were based on physicochemical properties to prompte tis-
sue-specific uptake into sensitive tissues (i.e., endocrine glands)22.  
1.4 Functionalization of cyanine dyes 
Functionalization of cyanine dyes if needed, can be achieved in both asymmetrical and symmet-
rical dyes. As such conjugation of cyanine dyes includes the use of either a symmetrical or an 
unsymmetrical cyanine dyes with functional groups are on the polymethine chain or part of the 
terminal heterocycles as shown in Figure 3 23-30.  
 
Figure 3 schematic representation of sites for bio-conjugation 
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For example, magnetic nanoparticles (MNPs) utilize functionalized dyes with iron oxide (Fe3O4) 
as bioimaging agents that allow for direct labeling of cancerous HeLa cells via both optically 
(NIR fluorescence microscopy) and thru magnetic resonance (MR) imaging31. The dye system 
can also be functionalized via encapsulation/micelle (micro- and nano-), as shown by ICG for 
self-assembly synthesis, tumor cell targeting, and photothermal capabilities32-34. Furthermore, 
dyes can be conjugated as fluorescent labels to provide alternative methods to monitor intracel-
lular reactions ,such as the intracellular delivery of antisense peptide nucleic acid by fluorescent 
mesoporous silica nanoparticles 30. The diversity of the dye scaffold can be seen in the different 
substitution on the meso-carbon in both penta-and heptamethine. In the case of pentamethine 
dyes, our lab has shown bio-conjugation via the meso-carbon on the cyanine dye as methods 
for trafficking scaffold degradation 35. More recently, substitution at the center carbon with hy-
droxyethyl piperazine functionalized at the meso-carbon, allows for selective colorimetric and 
ratiometric absorption responses to trivalent metal cations28.  
2 Synthesis of Asymmetric Monomethine Cyanine Dyes with Red-Shifted Optical Properties. 
This current chapter will briefly report on the synthesis of asymmetric monomethine cyanine 
dyes with red-shifted optical properties. Additional modeling studies were conducted to further 
understand the dyes’ photo physical properties to determine how substitution affect the optical 
properties of the dyes. Part of the this chapter of thesis was published in Journal of Heterocyclic 
Chemistry, (Vol 52, 180, 2015), and is presented thereafter in its published form 
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    10 
    11 
    12 
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2.1 Rationale  
When constructing new dyes for specific application, it is important to understand how varying 
the substituents on the dye would affect the optical properties of the dye. These changes can be 
made to improve solubility, increase binding and/or permeability, but these structural modifica-
tions also cause changes in both the absorption and fluorescence bands. Although many un-
symmetrical monomethine dyes have been made, there is a lack of current models for monome-
thine dyes with absorbance and fluorescence bands at wavelengths longer than 600 nm. Addi-
tionally the Stokes shifts of monomethine dyes are narrow (<50 nm). These limitations prompted 
the synthesis of new monomethine cyanine dyes that would have large Stokes shift values and 
red-shifted absorbance and fluorescence properties. Herein we report the synthesis of two se-
ries of unsymmetrical monomethine cyanine dyes with indolenine moieties to determine how 
substitutions affect the optical properties of the dyes. Furthermore, optical, NMR and modeling 
data were collected to assist in understanding how these substitution affect the optical proper-
ties of the dyes. 
2.2 Synthesis of Red Shift Monomethine dyes 
 
Scheme 5 Synthesis of red-shifted monomethine dyes 
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The synthetic preparation of the first set of asymmetric monomethine dyes 27a-g begins from 
the commercially available amide 20, constituting half of the dye, as shown in Scheme 6. This 
amide was then alkylated using iodobutane. The alkylated product 21 was then later trans-
formed into the thione 22 using phosphorous pentasulfide in pyridine at reflux. The thione was 
then converted into the methylsulfide 23 by means of iodomethane at reflux. The alternate half 
of the asymmetric dye begins with formation of the indole salt 25 (as shown in Scheme 6) via 
the alkylation the 5-subustitued indoles 24 under neat conditions. The synthesis of the indole 
begins with the reaction between the 4-substituted phenylhydrazines 24a-d with 3-methylbutan-
2-one that forms an enamine intermediate, which later undergoes a pericyclic rearrangement 
that is both catalyzed by the acidic environment and energetically driven by the formation into 
the aromatic indole 2536,37. The workup of that reaction included the use of a saturated solution 
of sodium bicarbonate to neutralize the reaction mixture (due to the increase of ammonium as 
byproduct from the cyclization) and to ensure the deprotonation of the indolenine nitrogen for 
subsequent reactions. After isolating the 5-substituted indolenine ring 25, various alkyl halides 
were used for quaternizing the N-indolenyl moiety for the reaction with the prepared salt 23. The 
synthesis of the monomethine cyanine dyes was then achieved via the condensation reaction of 
1-butyl-2-(methylthio)benzo[cd]indol-1-ium iodide 23 and an indolenine salts 26a-g in the pres-
ence of the basic reagent, triethylamine (TEA) in acetonitrile. The base was needed for the acti-
vation of indolium salt via the deprotonation of the methyl at the 2 position of the indole. After 
the deprotonation, the mechanism proceeds in a SN2 fashion in which the activated methylene 
group of the salts 25, displaces the methyl sulfide moiety of 23 and results in the formation of 
the asymmetrical monomethine dyes 27a-g. The dye reactions were monitored via both TLC 
and UV-Vis for completion. The dye reaction was completed when there was no change in the 
spectra of the reaction mixture and confirmed with TLC in a 1:20 MeOH:DCM (V/V) mixture. Af-
ter completion, the reaction mixture was concentrated under reduced pressure and dissolved in 
DCM to filter off the conjugate acid of TEA (triethylammonium chloride).  
    15 
 
Scheme 6 Synthesis of monomethine dyes 
 
The preparation of second set of the monomethine dyes 30a-c, shown in scheme 7 begin with 
the methylation of the nitrogen of the commercially available reagents 28a-c, 2-
methylbenzothiazole, 2-methylbenzoxazole or 1,1,2-trimethylbenzo[e]indole respectively. After 
alkylation using iodomethane, the heterocyclic salts 29a-c were condensed with salt (23) in the 
presence of the TEA in acetonitrile. The dye reactions were monitored via both TLC and UV-Vis 
for completion. The dye reaction was completed when there was no change in the spectra of the 
reaction mixture and confirmed with TLC in a 1:20 MeOH:DCM (V/V) mixture. Purification of the 
dyes was achieved via selective precipitation from MeOH in ether. After isolation, the dyes were 
characterized and their photo physical properties of the dyes were recorded. 
2.2.1.1 Optical Measurements Experimental 
2.2.1.1.1 Molar Absorptivity 
The absorption spectra were recorded on a Varian Cary 3G UV-Visible Spectrophotometer in-
terfaced with Cary WinUV Scan Application v3.00  at varying concentrations (µM) in cuvettes 
with a pathlength 1 cm.  
For each optical measurement, stock solutions were prepared by adding the appropriate mass 
of each individual compound on a five digit analytical balance to make a 1.0 mM solution.  From 
these stock solutions, the dilutions seen in appendix were obtained to determine the molar ab-
    16 
sorptivity values in methanol. For molar absorptivity values in glycerol/methanol (90% / 10% 
v/v), the concentrations for the solutions were prepared via the dilution of the stock solution in 
methanol and followed the addition of the appropriate volume of glycerol to achieve the desired 
concentrations. Furthermore, each solution was vortexed for 1 min and sonicated for 10 min and 
then its absorbance was measured. 
2.2.1.1.2 Fluorescence Data 
Florescence spectra for all monomethine cyanine dyes were obtained using a Shimadzu RF-
5301 Spectroflurophotometer (Shimadzu Corporation Analytical Instruments Division, Duisburg, 
F. R.  Germany). The parameters implemented for this procedure were as follows: slit width for 
both excitation and emission 5 nm; sensitivity was set on high; wavelength speed set to medi-
um; excitation wavelength 550 nm, and the light source was a 150 W Xenon lamp The fluorime-
ter was interfaced to a PC and data was collected using RF-5301PC software. Disposable poly-
styrene fluorescence cuvettes with a 1.00 cm pathlength were used for all measurements.  All 
fluorescence measurements were made using solutions of A < 0.1 to avoid inner filter effects. 
The data was analyzed and calculations were carried out using Microsoft Excel (Microsoft Cor-
poration, Redmond, Wa. 
2.2.1.2 Computational methods 
The Calculated LUMO and HOMO orbitals where obtained  using a restricted hybrid HF-DFT 
SCF calculation performed using Pulay DIIS + Geometric Direct Minimization and 6-31G* basis 
set , B3LYP Method via Spartan or Gassuioin(03). 
 
2.3 Characterization  
Compound 27b was chosen as a representative for complete chemical characterization and 
analysis. 1H NMR spectra of compound 27b was measured in DMSO-d6, is shown in Figure 4. 
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The aromatic region from 1H NMR spectra of compound 27b measured in DMSO-d6 can be 
seen in Figure 5. 
 
Figure 4 
1
H NMR spectrum of 27b in DMSO-d6 at 25°C 
 
Figure 5 Aromatc region of 
1
H NMR spectrum of 27b in DMSO-d6 at 25°C 
The structure of the dye can be classified into three parts and were colored accordingly, the two 
end terminals and the methine unit, as shown in Figure 5. As such, the structure of the dye 
would produce eleven signals in the aromatic region: four from the indole in red, one from the 
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proton of the methine and six from the benz[c,d]inolde in blue. The aliphatic region of the spec-
tra would have nine signals, one from the dimethyl’s of the indole in red and the butyl chains on 
the heteroatoms would provide eight. Analyzing the spectra in Figure 5, the proton from the me-
thine bridge would produce a singlet and is account for at 6.32 ppm, labeled in green in the 
spectra. The indole in red would provide a pair of triplets and doublets in the aromatic region of 
the spectra. The peaks at 8.36 (d, J = 7.85 Hz) 8.01 (d, J = 7.34 Hz), 7.55 (t, J = 7.77 Hz), and 
7.43 (t, J = 7.34 Hz) follow the expected splitting pattern from the red indole. Furthermore the 
integration, and the similar coupling constants (7.34-7.85 Hz), of these four peaks would sug-
gest that the protons from the indole in red. The peak 7.89 (t, J = 5.63 Hz) has a smaller cou-
plings value when compared to the other peaks; this suggest that it is in a different environment 
from the other peaks. The benz[c,d]indole would produce a splitting pattern of two triplets and 
four doublets. The multiplet at 7.70-7.77 integrates to four protons and the peak at 7. 89 (t, J = 
5.63 Hz)  integrates to two proton; based on the integration of a total of six proton from these 
peak in blue would correspond to the benz[c,d]indole.  
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Figure 6 
13
C NMR spectrum of 27b measured in DMSO-d6 at 25° C  
 
For compound 27b, there would a total of 29 distinct carbon on the molecule but only 27 signals 
from the carbons appear in the 13C NMR spectrum as seen in Figure 6. The 13C NMR spectrum 
of 27b measured in DMSO-d6 shows all 10 aliphatic carbons below 60 ppm. In the aromatic re-
gion of the 13C spectra, 16 of the aromatic carbons from the heterocycles appear with the range 
of 110 – 180 ppm with the peak at 83.93 ppm would correspond to the carbon of the methine 
bridge due to the sp2 nature of the carbon. All carbons except for two are accounted for, in 
which it is assumed that two of the five quaternary aromatic carbons are missing and would 
need more scans to show up on the spectra. The positive charge of the dyes is delocalized as 
shown in Figure 7. The LUMO and HOMO orbitals for dye 27b in Figure 8 
 
Figure 7 Resonance structure 
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Figure 8 Calculated LUMO (left) and HOMO (right) obrtial of 27b using Density Functional B3LYP force field and 6-
31G* data set. 
 
From the above diagram the majority HOMO orbitals are located are benz[c,d]indole moiety of 
the dye, demonstrating that the benz[c,d]indole acts as an electron sink, which account for the 
red-shift in absorbance bands due to further delocalization the positive charge on the dye mole-
cule. In contrast the LUMO orbitals are spread throughout the dye molecule, the majority of the 
orbitals across the methine chain and the indole. This model suggests that the indole has a 
higher electron density as shown by the HOMO calculations. Furthermore this electron density 
was also reflected in the 1H spectra, which the peaks of the indole appear in an alternating 
manner. These peaks are shifted based on the alternating density of connected carbons. 
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Figure 9 ESI mass spectra of 27b 
The mass spec was obtained via TOF ES+ wavelength absorption detector, ELSD, ESI mass 
spec and was utilized confirm purity, as show in Figure 9. The mass spectra showed only one 
ion peak that corresponds to the molecular weight of the compound that matches the calculated 
molecular weight of the dye 27b. All other spectra also showed a single signal that would corre-
spond to the dye only bring present  
2.4 Results and Discussion 
UV-Vis and emission spectra were recorded for dyes 27a, 30a-c in both MeOH and 90% glyc-
erol / 10% MeOH solutions as shown in Table 1. UV-Vis and emission spectra were recorded 
for dyes 27b-g in 90% glycerol / 10% MeOH solutions, as shown in Table 1.   
 
 
Dye 
λabs 
(nm)
a
 
λabs 
(nm)
b 
λemission 
(nm)
a 
λemission 
(nm)
b 
Stokes 
Shift 
(nm)
b
 
Stokes 
Shift 
(nm)
c
 
ε  
(L mol
-1  
cm
-1
)
a
 
ε  
(L mol
-1 
 
cm
-1
)
b
 
8a 537 556 592 657 101 55 33,300 - 
8b 556 565 N.O. 657 92 N.O. 30000 26200 
8c 564 571 N.O. 657 86 N.O. 23600 31300 
8d 562 568 N.O. 656 89 N.O. 32500 27300 
8e 564 572 N.O. 660 88 N.O. 33300 30900 
8f 565 572 N.O. 658 86 N.O. 30450 28500 
8g 567 575 N.O. 662 87 N.O. 33600 39900 
11a 555 N.R. 577 609 54 22 32300 N.R. 
11b 533 N.R. 589 570 72 58 37600 N.R. 
11c 553 N.R. 591 625 72 38 25300 N.R. 
Table 1 Wavelength of maximum for both absorbance and fluorescence and molar absorptivity in select sol-
vent: a: in methanol.;b in 90% glycerol/10% methanol (v/v); b in  methanol;N.O. Not observed in solution; N.R. Not 
recorded 
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When comparing dyes with and without substitutions at the 5-positition of the indole, the com-
pound fluorescence intensity decreases when compared to one another. The heavy atom effect 
has been shown to stabilize the excited state upon absorption of a photon which decreases lim-
its the compounds ability to emit photons. In addition to this the ﬂuorescence of these com-
pounds could not be observed in methanol alone because of the free rotation around the inter-
nuclear bridge resulting in a high nonradiative rate of return of the excited molecule—as cited 
with many monomethine cyanines containing the indolenine structure.38-40  
However, in viscous solution of 90% glycerol/10% MeOH (v/v), a fluorescence signal was ob-
served because of the hindered rotation of the dye molecule. Methanol was used in order to 
solubilize the compounds in the highly viscous glycerol. There was an average of 7 nm batho-
chromic shift in absorbance maxima in the 90% Glycerol / 10% MeOH (%v/%v) solution from 
the newly synthesized dyes 27b-g. Furthermore there was a decrease in the molar absorptivity 
values for a majority of the dyes synthesized. The electron deficient and conjugated system ac-
count for the red shifted absorbance wavelengths of the presented dyes would be responsible 
for the red shifted absorbance wavelengths when compared to a polyene system. the ben-
zo[c,d]indole moiety provides increased conjugation within the chromophore and an additional 
red shift of approximately 50 nm in absorbance when compared with previously synthesized 
asymmetric monomethine cyanines.2,41,42 The substitution on the 5 position of the indole by an 
electron withdrawing or electron donating group resulted in a red-shift of absorbance maxima 
via inductive effect of the electron system as shown in Figure 10 by the electronic potential 
maps (EMP) of dyes 27b-e.  
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Figure 10 Electrostatic Potential Maps (EMP) of Dyes 8b-e 
The inductive effect of different substituent is greater pronounced when comparing the molar 
absorptivity (ε) of the dyes. In addition, the computed charges for methine carbon following the 
same trend, as shown in Table 2.  An electron donating group decreased the ε value, due from 
increasing electron density thru the methoxy substituent. In contrast, the indoles with the elec-
tron withdrawing halogens increased the ε value for the system when both are compared to the 
non-substituted indole 27b as a result from decreasing the electron density thru the substitu-
tions.  
The alkyl side chains have little effect on the absorption and fluorescence maxima’s of the dyes 
as showed by dye 27a-g in Table 2.  
Dye 
charge of  
methine carbon 
Methine 
carbon shift (ppm 
Methine 
proton shift (ppm) 
λabs 
(nm) 
 
27a -0.626 82.78 6.31 537 
27b -0.584 83.57 6.31 556 
27c -0.635 84.00 6.31 564 
27d -0.632 83.93 6.25 562 
27e -0.668 83.69 6.29 564 
27f -0.632 83.69 6.34 565 
    24 
27g -0.693 83.12 6.76 567 
Table 2 
 
An common characteristic observed with this set of dyes is their broad absorbance spectra that 
can be attributed to a high level of aggregation, as shown using compound 27f in Figure 11.2 
 
Figure 11 Absorbance and emission spectra of 27f in 90% glycerol /10% methanol (v/v) at a dye concentra-
tion of at a dye concentration of 20 µM. 
 
Brooker et al. showed that If the basicity of the two nuclei is not equal the absorption would not 
be at the midpoint43. The substitution at Y as shown in both Table 3 and Figure 12 position of 
the indole resulted in either a hypsochromic or bathochromic shift of absorbance maxima when 
comparing the absorption spectra of the dyes 27a which are reflected the change basicity, of the 
heterocycles in dyes 27a, 30a-c.  
420 520 620 720 820 920
N
o
rn
a
li
z
e
d
 
A
b
s
o
rb
a
n
c
e
 
Wavelength (nm) 
Optical Properties of Compound 8f 
Emission
Absorbance
    25 
 
 
Table 3 Meso-proton shifts in relation to absorbance maxima in MeOH 
 
 
Figure 12 Absorbance spectra of select dyes in MeOH at 20 uM.  
 
The benzoxazole heterocycle influenced the conjugated system shown by shifting in both 1H 
peak of the methine-proton, as shown in Table 3 and absorbance spectra as shown in Figure 
30a 30b 
30c 
27a 
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12. The observed chemical shift of the methine-proton is most likely due to altering the electron 
density from the surrounding atoms. Oxygen is more electronegative then carbon, and therefore 
attracts more electronegativity from the methine chain corresponding to a λmax shift from 533 nm 
(30b) to 555 nm (30a) and a shift of methine-proton shift of 6.15 (30b) to 6.48 (30a) ppm  as 
show in Figure 12 and Figure 13 respectively. Sulfur is only slightly more electronegative than 
carbon causing a smaller methine-proton shift from 6.15 (30b) to 6.30 (27a) ppm and corre-
sponding a similar shift in λmax, 533 nm 30b to 537 27a. The broad shape of the UV-Vis spectra 
are relative similar when compared to each other for the all 27a-g, 30a, and 30c;expect for 30b 
which shows a spectra with two local maxima’s, as shown in Figure 12. An increase in conjuga-
tion leads to bathochromic shift of the absorbance maxima and corresponding to a λmax to 542 
as shown by 30c. Furthermore. The benz[e]indole heterocycle also shows the largest shift in 
both the meso-proton at 6.43 ppm and λmax both due to the lack of an electronegative element 
around the methine chain and increased conjugation in the heterocycle. 
In addition, an increase in absorbance maxima lead to a decrease in ε. The energy transitions in 
cyanine dyes have been shown to be a dominant π–π* transition.44,45 The HUMO and LUMO 
orbitals for the dyes 27a, 30a-c are shown in Figure 13. The energy gap between the highest 
occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) of com-
pound 30c is the lowest among all of the synthesized monomethine, 6.60 eV. This is likely due 
to the increased conjugation around the benz[e]indole heterocycle which led to further delocaliz-
ing of the electrons making the compound more stable. Compound 30a with the benzoxazole 
heterocycle shows the highest energy gap likely due to both the lone pair of electrons and elec-
tronegativity of the oxygen atom. The second highest energy gaps arise from 30b, the benzothi-
azole heterocycle derivative due to the lone pairs of the sulfur atom followed by 27a. In the set 
of compounds, the HOMO orbitals is spread evenly throughout the compound, while the LUMO 
orbitals is mostly in benz[c,d]indole heterocycle, which suggests that there is a high electron 
density is on the benz[c,d]indole; This is also observed in the EMP of the dyes. 
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Figure 13 The HUMO and LUMO obritals for the 8a, 11a-c  
2.5 Conclusion 
Monomethine cyanines were prepared with red shifted absorbance and fluorescence properties 
in comparison to previously synthesized asymmetric monomethines.  The 10 derivatives that 
were synthesized in good yield have large Stokes shifts. Additionally, when these dyes are with-
in a viscous environment, their fluorescence becomes observable which wouold allow for devel-
oping  viscosity-dependent fluorescence measurements and direct analyses of various envi-
ronments in biological systems46. Future work would include observing the dyes’ interaction with 
nucleic acids.  
2.6 Experimental 
Synthesis of 1-butylbenzo[cd]indol-2(1H)-one 21 
Synthesis of 1-butylbenzo[c,d]indol-2(1H)-one (21)was performed by adding 40% sodium hy-
droxide (22.3mmol, 0.7 mL) to a solution of the amide, benzo[c,d]indole-2(1H)-one (1.5 g, 8.9 
mmol) in 15mL of N-methyl-2-pyrrolidinone. Iodobutane (1.2 equiv) was then added dropwise to 
the reaction mixture, which was heated to 50 _C for 1 h, after which no starting material was 
27a    30a          30b    30c 
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visible on TLC. After cooling to room temperature, water (10 mL) was added, and the crude 
product was extracted with DCM and washed with brine. The organic layer was dried over an-
hydrous magnesium sulfate, gravity filtered, and concentrated in vacuo. The crude product was 
purified by flash column chromatography on silica gel using ethyl acetate/hexanes (1:10) as the 
eluting solvent.  
Synthesis of 1-butylbenzo[cd]indole-2(1H)-thione 22 
A mixture of amide 21 (200 mg) and diphosphorus pentasulfide (365 mg) in pyridine (8 mL) was 
refluxed for 2 h. The cooled reaction mixture was acidified with concentrated HCl and a red pre-
cipitate formed upon cooling. The crude product was filtered and dried. 1H NMR (300 MHz, 
DMSO-d6): d ppm 0.93 (t, J = 9.0 Hz, 3H), 1.39 (m, J = 9.0  Hz, 2H), 1.77 (m, J = 9.0 Hz, 2H), 
4.35 (t, J = 9.0 Hz, 2H), 7.46 (d, J = 6.0 Hz, 1H), 7.61 (t, J = 6.0 Hz, 1H), 7.77–7.84 (m, 2H), 
8.15 (d, J = 6.0 Hz, 1H), 8.24 (d, J = 9.0 Hz, 1H).  
Synthesis of 1-butyl-2-(methylthio)benzo[cd]indol-1-ium iodide 23 
A mixture of compound 22 and iodomethane (14 equiv) in the absence of solvent was heated to 
reflux for 8 h. The iodomethane was removed in vacuo. The resulting residue was treated with 
diethyl ether, and the mixture was sonicated for 30min and was suction filtered, washed with 
diethyl ether, and dried leaving an 82% yield. 1H NMR (400MHz, CDCl3): d ppm 0.82 (t, J = 7.6 
Hz, 3H), 1.39 (q, J = 7.6 Hz, 2H), 1.82 (m, J = 7.2 Hz, 2H), 4.51 (t, J = 7.2 Hz, 2H), 7.72 (t, J = 
8.0 Hz, 1H), 7.99 (t, J = 7.6 Hz, 1H), 8.10 (d, J = 8.0 Hz, 1H) , 8.21 (d, J=7.6Hz, 1H), 8.50 (d, 
J=7.6Hz, 1H), 8.99 (d, J=8.0Hz, 1H). 13C NMR (100 MHz, CDCl3): d ppm 12.73, 17.73, 19.16, 
29.47, 47.41, 117.02, 121.76, 127.29, 127.97, 128.12, 128.83, 130.47, 135.05, 136.93, 137.32, 
171.74 
General Synthetic Procedure for the indolium salts 
Compounds 26a-g were synthesized as previously reported. Each compound was then 
dissolved in acetonitrile (25 mL) and 4 molar equivalences (eq.) of the primary alkyl halide were 
added to the solution. The reaction mixture was then refluxed at 90° C for 72 h.  Thin layer 
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chromatography (TLC) was used to monitor the reaction in a solution of 4:1, DCM:hexanes. 
Upon cooling the reaction mixture to room temperature acetone was added followed by diethyl 
ether to precipitate the salt. The solid was filtered and washed with diethyl ether. The salts were 
used without further purification in subsequent reactions. 
Synthesis of 5-Bromo-2,3,3-trimethyl-1-(3-phenylpropyl)-3H-indol-1-ium bromide (26g) 
Compound 26 (0.02 mmol) was dissolved acetonitrile (25 mL) and to the solution 1-bromo-3-
phenylpropane (0.04 mmol, 20 mL) was added. The reaction mixture was then refluxed at 90° C 
for 72 h. Thin layer chromatography (TLC) was used to monitor the reaction using DCM:hexane 
(4:1) as eluting solvent. The reaction mixture was allowed to cool to room temperature; acetone 
was added to the mixture, followed by diethyl ether to precipitate the salt. The solid was 
collected via vacuum filtration and washed with diethyl ether to afford 26g as a dark brown solid. 
Yield 43%, 3.5 g, mp 160-161⁰ C; 1H NMR (400 MHz, CDCl3): 1.60 (s, 6H), 2.29 (m, J = 8.0 Hz, 
2H), 2.88 (t, J = 8.0 Hz, 2H), 3.03 (s, 3H), 4.79 (t, J = 8.0 Hz, 2H), 7.20 (d, J = 4.0 Hz, 3H), 7.29 
(d, J = 4.0 Hz, 2H) 7.50 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 2H) δ ppm 13C NMR (100 MHz, 
CDCl3): δ ppm 16.65, 23.17, 29.40, 32.57, 49.06, 54.83, 117.30, 124.47, 126.74, 126.90, 
128.59, 128.96, 132.80, 139.57, 140.17, 143.62, 196.46. 
Synthesis of 1-butylbenzo[c,d]indol-2(1H)-one (21) was performed by adding 40% sodium 
hydroxide (22.3 mmol, 0.7 mL) to a solution of benzo[cd]indole-2(1H)-thione (1.5 g, 8.9 mmol) in 
15 mL of N-methyl-2-pyrrolidinone.  Iodobutane (1.2 mol eq.) was then added dropwise to the 
reaction mixture which was heated to 50 oC for 1 h, after which no starting material was present 
on TLC.  After cooling to room temperature, water (10 mL) was added and the crude product 
was extracted with dichloromethane and washed with brine.  The organic layer was dried over 
anhydrous magnesium sulfate, gravity filtered, and concentrated in vacuo. The crude product 
was purified by flash column chromatography on silica gel using ethyl acetate:hexanes (1:10) as 
the eluting solvent. 
Synthesis of 1-butylbenzo[c,d]indole-2(1H)-thione (22). A mixture of amide (200 mg) and 
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diphosphorous pentasulphide (365 mg) in pyridine (8 mL) was refluxed for 2 h.  The cooled 
reaction mixture was acidified with concentrated HCl and a red precipitate formed upon cooling.  
The crude product was filtered and dried. 1H NMR (300 MHz, DMSO-d6): δ ppm 0.93 (t, J = 9.0 
Hz, 3H), 1.39 (m, J = 9.0 Hz, 2H), 1.77 (m, J = 9.0 Hz, 2H), 4.35 (t, J = 9.0 Hz, 2H), 7.46 (d, J = 
6.0 Hz, 1H), 7.61 (t, J = 6.0 Hz, 1H), 7.77-7.84 (m, 2H), 8.15 (d, J = 6.0 Hz, 1H), 8.24 (d, J = 9.0 
Hz, 1H). 
Synthesis of 1-butyl-2-(methylthio)benzo[c,d]indol-1-ium iodide (23).  A mixture of 
compound 3 and iodomethane (14 mol. eq.) in the absence of solvent was heated to reflux for 8 
h.  The iodomethane was removed in vacuo. The resulting residue was treated with diethyl ether 
and the mixture was sonicated for 30 minutes and was suction filtered, washed with diethyl 
ether, and dried leaving an 82% yield. 1H NMR (400 MHz, CDCl3): δ ppm 0.82 (t, J = 8.0 Hz, 
3H), 1.39 (m, J = 8.0 Hz, 2H), 1.82 (m, J = 8.0 Hz, 2H), 4.51 (t, J = 8.0 Hz, 2H), 7.72 (t, J = 8.0 
Hz, 1H), 7.99 (t, J = 8.0 Hz, 1H), 8.10 (d, J = 8.0 Hz, 1H) , 8.21 (d, J = 8.0 Hz, 1H), 8.50 (d, J = 
8.0 Hz, 1H), 8.99 (d, J = 8.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ ppm 12.73, 17.73, 19.16, 
29.47, 47.41, 117.02, 121.76, 127.29, 127.97, 128.12, 128.83, 130.47, 135.05, 136.93, 137.32, 
171.74  
General Synthesis of the monomethine dyes 
Compound 23 was dissolved in 10 mL of CH3CN and 1.5 mol. eq. each, of the appropriate 
indolium salt and triethlyamine was added to the solution. The reaction mixture was refluxed at 
60° C for 1 hr. UV-Vis was used to monitor the reaction. 
Upon cooling to room temperature, diethyl ether was added to the reaction mixture to precipitate 
the dye. The solid was collected and washed with deionized water and diethyl ether. The dyes 
were purified via recrystallization by solvation in a minimal amount of methanol and dilution with 
diethyl ether causing precipitation. 
(E)-1,3,3-trimethyl-2-((1-methylbenzo[cd]indol-2(1H)-ylidene)methyl)-3H-indol-1-ium 
iodide 27a (lo 5)1H NMR (400 MHz, DMSO-d6) d ppm 0.95 (t, J=7.08 Hz, 3 H) 1.45 (sxt, J = 
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7.30 Hz, 2 H) 1.65 (s, 6 H) 1.86 (quin, J = 7.30 Hz, 2 H) 3.47 (s, 3 H) 4.45 (t, J=7.50 Hz, 2 H) 
6.31 (s, 1 H) 7.44 (t, J=7.34 Hz, 1 H) 7.51 - 7.63 (m, 2 H) 7.69 - 7.85 (m, 4 H) 7.88 - 7.96 (m, 2 
H) 8.37 (d, J = 8.02 Hz, 1 H): 13C NMR (100 MHz, DMSO-d6): XX 
(E)-1-Butyl-2-((1-butyl-3,3-dimethylindolin-2-ylidene)methyl)benzo[c,d]indol-1-ium iodide 
(27b); Yield 66 %, 0.48 g; mp 220-221⁰ C  1H NMR (400 MHz, DMSO-d6): δ ppm ppm 0.62 (t, J 
= 8.0 Hz, 3H), 0.90 (t, J = 8.0 Hz, 3H), 1.00 (m, J = 4.0 Hz, 2H), 1.40 (m, J = 4.0 Hz, 2H), 1.64 
(s, 8H), 1.80 (m, J = 8.0 Hz, 2H), 4.18 (s, 2H), 4.49 (s, 2H), 6.31 (s, 1H), 7.41 (t, J = 4.0 Hz, 1H), 
7.53 (t, J = 8.0 Hz, 1H), 7.73 (m, 4H), 7.91 (m, 2H), 8.00 (d, J = 4.0 Hz, 1H), 8.35 (d, J = 8.0 Hz, 
1H); 13C NMR (100 MHz, DMSO-d6): δ ppm 12.94, 13.35, 18.34, 19.15, 25.37, 28.89, 29.53, 
43.27, 49.78, 51.32, 83.57, 110.71, 113.99, 122.82, 122.95, 123.46, 126.05, 128.14, 128.87, 
129.22, 129.67, 132.41, 140.24, 140.35, 141.44, 155.54, 180.08; λabs = 556 nm in MeOH.  
HRMS (ESI) calculated for [C30H35N2]
1+ m/z 423.2795, found m/z 423.1447 
(E)-1-Butyl-2-((1-butyl-5-chloro-3,3-dimethylindolin-2-ylidene)methyl)benzo[c,d]indol-1-
ium iodide (27c); Yield 34%, 0.40 g; mp 197-198⁰ C; 1H NMR (400 MHz, DMSO-d6): δ ppm  
0.62 (t, J = 8.0 Hz, 3H), 0.91 (t, J = 8 Hz, 3H), 0.99 (m, 2H), 1.40 (m, 2H), 1.59 (m, 2H), 1.64 (s, 
6H), 1.81 (m, 2H), 4.14 (m, 2H), 4.52 (m, 2H), 6.30 (s, 1H), 7.60 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 
8.0 Hz, 1H), 7.78 (m, 2H), 7.90 (m, 3H), 7.89-7.78 (m, 2H), 7.90 (s, 1H), 8.07 (d, J = 8.0 Hz, 
1H), 8.39 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ ppm 13.26, 13.66, 18.64, 19.46, 
25.65, 29.03, 29.93, 43.75, 50.28, 51.58, 84.00, 111.73, 115.66, 123.55, 123.66, 123.81, 
128.84, 129.00, 129.13, 129.27, 129.56, 129.98, 130.09, 130.62, 133.14, 140.52, 140.83, 
142.59, 156.40, 179.80; m.p. 197-198⁰ C; λabs = 562 nm in MeOH.  HRMS (ESI) calculated for 
[C30H34ClN2]
1+ m/z 458.0568, found m/z 458.7525 
(E)-1-butyl-2-((1-butyl-5-methoxy-3,3-dimethylindolin-2-ylidene)methyl)benzo[c,d]indol-1-
ium iodide (27d); Yield 50%, 0.24 g, mp 174-175⁰ C; 1H NMR (400 MHz, DMSO-d6): δ ppm 
0.65 (t, J = 8.0 Hz, 3H), 0.90 (t, J = 8.0 Hz, 3H), 1.02 (m, J = 8.0 Hz, 2H), 1.39 (m, J = 8.0 Hz, 
2H), 1.63 (s, 8H), 1.80 (t, J = 8.0 Hz, 2H), 3.86 (s, 3H), 4.18 (t, 2H), 4.43 (t, J = 8.0 Hz, 2H), 6.25 
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(s, 1H), 7.10 (d, J = 8.0 Hz, 1H), 7.41 (s, 1H), 7.62-7.71 (m, 3H), 7.81-7.85 (m, 3H), 8.30 (d, J = 
8.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ ppm 13.49, 13.92, 18.84, 19.72, 25.63, 29.54, 
29.96, 43.54, 50.38, 52.18, 56.16, 83.93, 109.65, 110.11, 114.05, 115.69, 122.63, 124.24, 
127.56, 129.55, 129.76, 130.15, 130.20, 132.29, 135.10, 141.17, 142.92, 154.81, 159.08, 
180.29; λabs= 564 nm in MeOH. HRMS (ESI) calculated for [C31H37ClN2O]
1+ m/z 453.2900, found 
m/z 453.2441 
(E)-2-((5-Bromo-1-ethyl-3,3-dimethylindolin-2-ylidene)methyl)-1-butylbenzo[c,d]indol-1-
ium iodide  
(27e); Yield 25%, 0.12g, mp 195-196⁰ C; 1H NMR (400 MHz, DMSO-d6): δ ppm  0.93 (t, J = 8.0 
Hz, 3H), 1.10 (t, J = 8.0 Hz, 3H), 1.41 (m, 2H), 1.64 (s, 6H), 1.84 (t, J = 8.0 Hz, 2H), 4.17 (m, 
2H), 4.49 (t, J = 6.0 Hz, 2H), 6.29 (s, 1H) , 7.62 (d, J = 12.0 Hz, 1H) 7.73-7.81 (m, 3H), 7.88-
7.95 (m, 2H), 8.02 (s, 1H), 8.13 (d, J = 4.0 Hz, 1H), 8.40 (d, J = 4.0 Hz, 1H); 13C NMR (100 MHz, 
MeOD-d4): δ ppm 12.66, 13.49, 13.65, 20.44, 25.49, 30.91, 72.81, 83.69, 84.64, 112.53, 115.69, 
120.11, 124.92, 124.98, 127.00, 129.13, 130.07, 130.53, 131.02, 132.22, 134.07, 141.26, 
141.26, 141.78, 143.44, 158.41, 179.99; λabs= 564 nm in MeOH; HRMS (ESI) calculated for 
[C28H30BrN2]
1+ m/z 473.1567, found m/z 473.0529. 
(E)-2-((5-Bromo-1-butyl-3,3-dimethylindolin-2-ylidene)methyl)-1-butylbenzo[c,d]indol-1-
ium iodide (27f); Yield 54%; 0.46g, mp 187-186⁰ C; 1H NMR (400 MHz, DMSO-d6): δ ppm  
0.59 (s, 3H), 0.90 (s, 3H), 0.97 (m, 2H), 1.38 (m, 2H), 1.57 (s, 2H), 1.67 (s, 6H), 1.82 (m, 2H), 
4.13 (s, 2H), 4.54 (s, 2H), 6.34 (s, 1H), 7.67-7.77 (m, 4H), 7.90 (m, 2H), 8.02 (s, 1H), 8.06 (d, J 
= 4.0 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ ppm 12.78, 13.19, 
18.19, 18.98, 25.27, 28.55, 29.47, 43.44, 48.09, 49.84, 51.14, 83.69, 111.33, 115.64, 118.25, 
123.09, 123.34, 125.84, 128.58, 129.05, 129.43, 129.66, 130.69, 132.64, 139.95, 140.78, 
142.41, 155.95, 179.08; λabs= 565 nm in MeOH; HRMS (ESI) calculated for [C30H34BrN2]
1+ m/z 
502.5078, found m/z 502.7264. 
(E)-2-((5-Bromo-3,3-dimethyl-1-(3-phenylpropyl)indolin-2-ylidene)methyl)-1-
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butylbenzo[c,d]indol-1-ium iodide (27g); Yield 32 %, 0.29 g, m.p. 201-202⁰ C; 1H NMR (400 
MHz, DMSO-d6): δ ppm 0.92 (t, J = 8 Hz, 3H), 1.40 (m, 2H), 1.65 (s, 6H), 1.74 (m, 2H), 1.84 (m, 
2H), 2.40 (m, 2H), 4.10 (m, 2H), 4.41 (m, 2H), 6.19 (s, 1H), 6.76 (m, 5H), 7.66 (d, J = 4 Hz, 1H) 
7.68 (q, J = 8 Hz, 2H), 7.78 (s, 2H),  7.88 (t, J = 6 Hz,  1H), 7.98 (m, 1H), 8.02 (s, 1H), 8.08 (d, J 
= 8 Hz), 8.40 (d, J = 4Hz, 1H) 13C NMR (100 MHz, DMSO-d6): δ ppm 13.21, 19.02, 25.29, 28.31, 
29.54, 30.99, 49.11, 51.02, 83.12, 111.50, 115.30, 118.11, 123.11, 123.55, 124.96, 125.83, 
126.4, 127.13, 127.22, 127.92, 128.80, 129.00, 129.38, 130.69, 132.74, 139.37, 139.81, 141.02, 
142.32, 155.95, 178.11; λabs= 567 nm in MeOH; HRMS (ESI) calculated for [C35H36BrN2]
1+ m/z 
563.2056, found m/z 563.0953. 
1-butyl-2-((3-methylbenzo[d]thiazol-2(3H)-ylidene)methyl)benzo[cd]indol-1-ium Iodide 
(30a); Yield 57 %; 1H NMR (400 MHz, DMSO-d6) δ ppm 0.96 (t, J = 7.07 Hz, 3 H) 1.37 - 1.57 
(m, 2 H) 1.74 - 1.94 (m, 2 H) 4.05 (s, 3 H) 4.48 (t, J = 6.57 Hz, 2 H) 6.15 (br. s., 1 H) 7.56 - 7.68 
(m, 3 H) 7.73 (t, J = 7.58 Hz, 1 H) 7.80 - 7.92 (m, 2 H) 8.04 (t, J = 7.71 Hz, 1 H) 8.15 (d, J = 7.58 
Hz, 1 H) 8.40 (d, J = 8.08 Hz, 1 H) 9.17 (d, J=7.07 Hz, 1 H) ; 13C NMR (100 MHz, DMSO-d6): δ 
ppm13.96, 19.49, 29.66, 31.41, 43.09, 74.91, 109.49, 111.74, 112.01, 122.36, 125.99, 126.65, 
127.91, 129.09, 129.17, 129.67, 129.84, 131.26, 132.33, 140.51, 146.24, 154.99, 161.40 
1-butyl-2-((3-methylbenzo[d]oxazol-2(3H)-ylidene)methyl)benzo[cd]indol-1-ium Iodide 
(30b); Yield 69 %1H NMR (400 MHz, DMSO-d6) δ ppm 0.80 - 1.11 (m, 3 H) 1.46 (d, J = 6.57 Hz, 
2 H) 1.82 (br. s., 2 H) 4.16 (br. s., 3 H) 4.37 (br. s., 2 H) 6.48 (br. s., 1 H) 7.55 (d, J = 6.82 Hz, 1 
H) 7.67 (dd, J = 19.96, 7.07 Hz, 2 H) 7.72 - 7.83 (m, 2 H) 7.88 (t, J = 7.58 Hz, 1 H) 8.04 (d, 
J=8.08 Hz, 1 H) 8.21 (d, J = 7.33 Hz, 1 H) 8.32 (d, J=8.08 Hz, 1 H) 9.24 (d, J = 7.07 Hz, 1 H); 
13C NMR (100 MHz, DMSO-d6): δ ppm 14.23, 20.13, 30.07, 35.81, 43.79, 87.40, 109.46, 
115.35, 122.44, 124.02, 125.07, 125.73, 127.17, 127.33, 129.23, 128.65, 130.06, 130.12, 
132.73, 141.43, 141.63, 154.71, 166.28  
(E)-1-butyl-2-((1,1,3-trimethyl-1,3-dihydro-2H-benzo[e]indol-2-ylidene)methyl)benzo[cd]indol-1-
ium iodide ( 30c);
 1H NMR (400 MHz, DMSO-d6) d ppm 0.95 (t, J=7.34 Hz, 3 H) 1.45 (sxt, J = 
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6.80 Hz, 2 H) 1.81 - 1.93 (m, 8 H) 3.60 (s, 3 H) 4.46 (t, J = 7.70 Hz, 2 H) 6.43 (s, 1 H) 7.60 (t, J 
= 7.34 Hz, 1 H) 7.66 - 7.78 (m, 3 H) 7.81 (d, J = 7.34 Hz, 1 H) 7.85 - 7.92 (m, 3 H) 8.14 (d, J = 
8.02 Hz, 1 H) 8.21 (d, J = 8.70 Hz, 1 H), 8.35 (s, 2 H). 13C NMR (400 MHz, DMSO-d6) 
3 Synthesis and Assessment of Symmetrical Pentamethine Cyanine Dye with Quinoline and 
Phenanthridine Terminal Heterocycles as Potential Photo-Induced Cleaving Agents for 
DNA 
This chapter reports the synthesis of series of symmetrical polymethine dye with quinoline and 
phenanthridine as terminal heterocycles and their activity of photo-included cleavage against 
pU16 supercoiled DNA.  
3.1 Photodynamic , an Introduction 
Methods for heliotherapy, (the therapeutic use of light) have been dated as far back as 1400 
B.C and in1903, the Nobel Prize in Physiology or Medicine was awarded to Niels Ryberg Fin-
sen, for his methods utilizing light for the treatments lupus vulgaris (a skin disease)47-49. The light 
used in the treatments can originate either from an artificial source, natural source, or as a com-
bination of both artificial and natural sources. The combination of light source and an external 
agent, usually photosensitizer, constitutes photochemotherapy. Photodynamic therapy (PDT) is 
a type of photochemotherapy which using light, a photosensitizer, and molecular oxygen for 
treatments50. The selective accumulation of a photosensitizer at the target, such as cancer cells 
followed by excitation via an appropriate light source, is the mode in which PDT obtains its ther-
apeutic properties51. Photothremal therapy (PTT), in another form of phototherapy which causes 
celluar damage (hyperthermia) through the conversion of energy to heat by the photosensitizer 
from the absorbed photons.32 In general a photosensitizer is a molecule that is capable of ab-
sorbing light energy and transferring that energy to an adjacent molecules/system. A photosen-
sitizer as a theranostic agent would have specific physical and photo-physical properties. The 
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idea physical properties of the photosensitizer would include qualities that allow selectivity, low 
toxicity for both the photosensitizer and its metabolites and excretion from the body upon com-
pletion of treatment. The photo-physical properties of the model photosensitizer include absorp-
tion in the NIR therapeutic window (650–800 nm), high extinction coefficient (ε >50,000–
100,000 M−1 cm−1) and treatment dependent properties, such as a high singlet oxygen quantum 
yield (ΦΔ) for PDT. FDA approved sensitizers for PDT are shown in Figure 14. 
 
Figure 14 FDA approved sensitizer for PDT. 
3.2 Photochemothreapy mechanism  
 
Figure 15 Motifs for photosensitizers for PDT agents classes; absorbing unit in red 
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Although photosensitizer can range from very simple organic molecules such as ALA, to ex-
tended organometallic or supramolecular aggregates, they are described as a molecule that is 
efficient at absorbing photons and transferring that energy to other molecules with common or-
ganic motifs for photosensitizers includes furanocoumarin, porphyrinoid, anthraquinone, phthal-
ocyanine, phenothiazine, bodipy and squaraine bases, as shown in Figure 1547,50,52. The conju-
gation of in the photosensitizer agents allow for the compound to absorb light, where the energy 
transfer is called the photosensitized reaction. Both PTT and PDT utilizes the sensitizer in an 
excited state for the energy transfer to induce damage to cause damage to targets. A requisite 
for the energy transfer, is that the lifetime of the molecule in the excited state must be long 
enough for the reaction53,54. When an organic molecule absorbs light, the absorbed photon pro-
motes the molecule from a singlet ground state (1PS) to a singlet excited state (1PS*) as shown 
in Figure 16. This 1PS*) state can stabilize either via a radiative process such as the singlet–
singlet emission called fluorescence, or via non-radiative intersystem crossing from the singlet 
to triplet state (3PS*). The energy of the 3PS* species can also dissipated via the radiative tri-
plet–singlet emission process, called phosphorescence. Another pathway for the excitation en-
ergy is for it to thermally dissipate via internal conversion.  
 
Figure 16 Adapted Jablonwski Diagram to show PDT mecanishm; isc (intersystem crossing) ic (internal conversion) fl 
(fluorescence) abs (absorbance) ph (phosphorescence) 
 
In PDT the photosensitizer is excited at specific wavelength, which then produces reactive oxy-
gen species (ROS), such as singlet oxygen (1O2) or free radicals (●OH) by transferring the ab-
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sorbed energy to surrounding oxygen molecules. The energy transfer can occur via two different 
pathways, Type I and Type II, as shown in Figure 16. Type I mechanisms are classified when 
ROS are generated thru secondary reactions (energy transfer thru an intermediate and then to 
O2 to generate ROS).Type II mechanism are classified by the direct energy transfer from the 
photosensitizer to molecular oxygen (O2). Nonetheless, both phototherapies utilize a photosen-
sitizer that absorbs light to achieve selective cell death and tissue devastation either via an en-
ergy transfer (PDT) or energy conversion (PTT) for efficacy50.  
3.3 Logic of photosensitizing Agent  
A large percentage of chemotherapeutic anticancer drugs are compounds that interact with 
DNA 55. DNA fundamental role in biology is to store genetic information, thus its stability against 
external perturbations is essential yet selective DNA oxidation is the mode in which the photo-
sensitizers in both PDT and PTT obtain theranostic properties50-54,56. The cellular damage is de-
pendent on the properties of the photosensitizer in both excited states and location within the 
cell with the direct triplet energy transfer to the DNA nucleobases leading to irreversible DNA 
lesions. The anatomy of a photosensitizer may be understood summarized into two parts: the 
chromophore and its peripheral modifications. The first grants both light absorption/emission 
and photosensitizing properties, while the later are important to their physical properties that 
affect both drug distribution and uptake such as lipophilicity. Among the many conjugated sys-
tems, cyanine dyes have been adapted to assume properties that would enable it to selectively 
target and assume absorbance/fluorescence bands in the desired therapeutic NIR window 600–
800 nm range.  
Example of photosensitized DNA cleavage have been reported for both monomethine dyes 
based on derivatives of YO and TO for both ss-DNA and ds-DNA but their short wavelength 
bands limit their therapeutic development57,58. Furthermore,  the Henary lab has synthesized a 
series Meso-substituted pentamethine with benz[e]indolium terminal heterocycles were shown 
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that oxidatively cleave U19 plasmid DNA21. Using this finding, the photosensitizing dyes would 
incorporate the pentamethine, to provide model photo physical properties such as absorbancein 
the near-infrared (>650 nm) region of the electromagnetic spectrum13. This in return would allow 
for lower energy excitation sources to be during treatments. With the collaboration with Dr. 
Grants Lab, the synthesized dyes where  evaluated for the photo-induced cleaving activity 
against pU19 plasmid DNA. The prospective photosensitizing dyes would incorporate phenan-
thridine and quinoline, as the terminal heterocycles in the cyanine system. Also, to study the 
effect of the polymethine chain, the selected heterocycles would also be synthesized in the tri-
methine fashion. The phenanthridine and quinoline core where outlined from Ethidium bromide, 
a well-documented nucleic stain, as shown in Figure 17. The assumption is made that the flat 
cationic heterocycles would promote would stronger interaction with DNA. 
 
Figure 17 Structure of Ethidium bromide with the phenanthridine core outlined in red and quinoline in blue 
 
3.4 Synthesis of Photosensitizing Polymethine Dyes 
Two sets of dyes were synthesized, with the first set consisting of dyes with phenanthridine, as 
shown in Scheme 7. The synthetic preparation of the symmetric polymethine cyanine dye con-
sists of the condensation of two salts, quaternary salt 34 and a polymethine agent (37 or 38). 
Synthesis of the first part 34, began with formation of the 6-methylphenanthridine 33 which was 
isolated in two steps. The amide 32 , afforded by the acetylation of the 2-aminobiphenyl 3 with 
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acetic anhydride (Ac2O) and was proceeded by the dehydrative ring closure via the Morgan-
Walls reaction with phosphoryl chloride (POCl3) under nitrogen. A saturated solution of sodium 
carbonate (Na2CO3) was used to neutralize the reaction mixture due to the increase of acidic 
byproduct from the cyclization and to ensure the of the phenanthridine nitrogen for subsequent 
reactions.  
 
Scheme 7 Synthesis of novel Phenatridine containg  dyes; 39 Commercial  reagent 
After isolation of the phenanthridine ring 33 thru extraction, various alkyl halides were used for 
quaternizing the N-phenanthridinyl to afford the salts, 34a-c. The N-methyl salt 34a was used to 
prepared trimethine dye 36 via the base catalyzed condensation with triethyl ortho formate 
(CH(OEt)3) in Ac2O. The pentinthein dyes 35a-f where synthesized with altering substitution on 
the pentamethine chain. The halogenated polymethine precursors were generated by reacting 
aniline with either mucochloric 38a or mucobromic 38b acid in ethanol with light heating. The 
base catalyzed condensation was then proceed between the prepared phenanthridinium salts 
with either the commercially available polymethine reagent, 39 or synthesized the halogenated 
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polymethine reagents 38a or 38b. Trimethylamine (TEA) was used as the base in the conden-
sation reaction to afford the polymethine dyes. The base in reaction caused the deprotonation of 
the methyl at the 6 position and acetic anhydride catalyzed the reaction.  
 
Scheme 8 Synthesis of novel 4-quinyl containing dyes  
 
The second set of series of dyes, shown in Scheme 8 were prepared from the commercially 
available 4-methyl quinoline. The quinoline was alkylated in acetonitrile with the appropriate hal-
ide to afford the salts 40a-c. The second step was proceeded by base-catalyzed condensation 
of salts with either polymethine linker 38 or 39 in acetic anhydride with TEA, to afford the pen-
tamethine dyes, 42a-g. The trimethine dye 41 was synthesized by the condensation of quater-
nary salt 40a with equal mols of TEA as base in triethylortho formate (CH(OEt) 3). Both sets of 
dyes were either purified via column chromatography using DCM:MeOH solvent mixture or se-
lective precipitation from methanol in ether. Both 1HNMR and 13CNMR was used to structurally 
analyze the dyes synthesized. 
3.4.1.1.1 Molar Absorptivity 
The absorption spectra were recorded on a Varian Cary 3G UV-Visible Spectrophotometer in-
terfaced with Cary WinUV Scan Application v3.00 at varying concentrations (µM) in cuvettes 
with a pathlength 1 cm. For each optical measurement, stock solutions were prepared by adding 
the appropriate mass of each individual compound on a five digit analytical balance to make a 
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1.0 mM solution.  From these stock solutions, the dilutions seen in appendix were obtained to 
determine the molar absorptivity values in methanol.  
3.4.1.2 Computational methods 
The Calculated LUMO and HOMO orbitals where obtained  using a restricted hybrid HF-DFT 
SCF calculation performed using Pulay DIIS + Geometric Direct Minimization and 6-31G* basis 
set , B3LYP Method via Spartan or Gassuioin(03). 
3.5 Characterization 
Compound 35c was chosen as a representative for characterization and analysis of set of pen-
tamethine dyes 35. The 1H NMR spectra of compound 35f measured in DMSO-d6 can be seen 
in Figure 18. The structure of the dye can be classified into two parts, the phenanthridine termi-
nal and the poly-methine bridge. The phenanthridine ring was colored based on the nomencla-
ture of heterocyclic compounds, benzo[c]quinoline and the polymethine chainin in green in Fig-
ure 18. There are five protons on the polymethine chain and sixteen protons on the heterocyclic 
ring system, yet the symmetrical nature of the dye allows for two equivalent proton of all protons 
except the proton of the center carbon. Therefore, the dye would have 15 protons peaks that 
would appear in the spectra, eleven in the aromatic region and four in the aliphatic region of the 
spectra, respectively.  
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Figure 18 
1
H NMR spectrum of 35f in DMSO-d6 at 25°C  
  
The spectra in Figure 19 shows eight peak signals in the aromatic region and four in the aliphat-
ic region of the spectra. The polymethine chain would produce two triplets and a doublet and 
would account for three peaks in the spectra. The phenanthridine (benzo[c]quinoline) ring would 
produce a splitting pattern of would result in both four doublets and triplets. , for a total of eight 
signals but the 1H NMR only of 35f in either solvent, (DMSO-d6 or CDCl3-d) produced less than 
eight signals that would correspond to the ring system due to the overlapping of peaks as 
shown in Figure 21. 
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Figure 19: Proposed 
1
H labeling of Aromatc region of 
1
H NMR spectrum of 35f in DMSO-d6 /(top) and CD3Cl-d3 (bottom) at 25°C  
 
An effort was made to correlate the protons signals to the structure of dye 35f as the proton as-
signment found in Figure 19, in which each colored part of structure would tiers respective peak 
that are coupled  based on integration, splitting pattern and coupling constant (J [Hz]). The three 
furthest peaks up-field in DMSO, have both similar and large coupling values (J >12 Hz) when 
compared to signals further downfield (J < 9 Hz). The integration, splitting patterns and similar 
coupling constant (J [Hz]) of the peaks at 6.75(d), 6.83 (t), 7.46(t) ppm would corresponds to 
five protons of the methane chain, labelled in green. The CDCl3-d spectra also show three 
peaks with large and similar coupling constant, and are also labeled in green in Figure 19. The 
HOMO and LUMO orbitals as shown in Figure 20, reflect the alternating charges on the carbon 
atoms in the methine chain. the calculated charges of the carbon also show alternating net 
charges spread across the dye.  
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Figure 20 Calculated LUMO and HOMO orbital of 35a using DFT with B3YLP and 6-311+G data set. 
 
  
Figure 21 Electrostatic Potential map (left) and electrostatic charges (right) calculated using DFT with B3YLP and 6-
311+G basis set of dye 35a 
 
Further analyzing the 1HNMR spectrum in DMSO-d6,in Figure 21, two are the peaks with cou-
pling values larger than 8 Hz suggesting that they are part of the same environment and were 
labeled in blue.. The triplet at 8.63 (J = 8.11 Hz) ppm integrates total of four protons, suggesting 
that there are two protons from the ring. The multiplet from 7.72-7.78 ppm appears be the result 
of two doublets due to the space between the peaks (8 Hz) being smaller than the coupling 
constant of the peaks, J = 9.39 Hz; the large coupling constant suggests that it belong to the 
ring in blue.  The doublet at 8.23 (J = 7.85 Hz) and triplet 7.74 (J = 7.68 Hz), at would corre-
spond to two protons from the ring labeled in red, due to having similar coupling constant. The 
remaining protons from the ring in red are account for in multiplet from 7.89-7.96 ppm, which 
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integrates to two protons; the peak shape appearing to be the result of two overlapping peaks 
and would account for the other two proton of the ring in red. 
Analyzing the 1HNMR spectrum in CDCl3-d in Figure 21, the peak furthest downfield integrates 
to four protons, indicating two protons. This doublet at 8.32 (J = 7.83 Hz) and the triplet at 7.81 
(J = 7.58 Hz) have a similar coupling value, similar the ring in red, as established in the DMSO 
spectra. The integration of these two peak accounts for to two from the ring in red. The multiplet 
at 7.41 -7.47 integrates to four protons and appear to be a doublet and triplet. However, the dif-
ferent coupling values suggest that these are two protons from different rings, 6.32 vs 13.14 Hz; 
one from the methane chain and the other from the ring in red as the last peak from the ring . 
When comparing the aromatic region of 36f CDCl3-d spectra showed a doublet with a coupling 
constant of 8.1 Hz, indicating that it belongs to the ring colored in blue. The multiplet 7.64-7.70 
ppm integrates to six proton which indicate other three proton of the ring in blue since the other 
protons have already be assigned.  
.  
 
Figure 22 A  3D model representation of 35f 
 
The overall structure of the dyes with the phenanthridine is bent as shown in Figure 22 when 
compared to the quinoline dyes which are flat as shown in Figure 23a. The bent shape of the 
molecule could due to both the electrostatic repulsion and steric hinderence from the hydrogens 
of the polymethine chain and phenanthridine ring. Nonetheless, the HOMO and LUMO show 
similar electron density across the polymethine chain as shown in Figure 23b.  
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Figure 23 A Electrostatic Potential map EPM of 42a B} 3D model representation of 42a C) electrostatic charges 
(right) calculated using density functional theory with B3YLP and 6-311+G basis set 
 
Figure 24 The HOMO(left) and LUMO (right) of 42a 
 
As such, dye 42d was chosen for complete characterization, as representative example for dyes 
42. The structure of the dye 42d can be classified into two parts, the quinoline terminal and the 
poly-methine bridge, thus there are five protons on the polymethine chain and twelve protons on 
the heterocyclic ring system. The symmetrical nature of the dye allows for two equivalent proton 
of all protons except the proton of the center carbon. Thus the dye would have eleven protons 
peaks that would appear in the spectra, nine in the aromatic region and two in the aliphatic re-
gion of the spectra, respectively. The 1H NMR spectra of compound 42b measured in DMSO-d6 
can be seen in Figure 25. In Figure 26 an attempt was made to assign the protons signals in the 
aromatic region of the 1HNMR spectra of the dye 42d.   
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Figure 251HNMR spectra of the dye 42b.  
  
The proton signal assignment were based on integration, splitting patterns and electron density; 
the colored labeling found in in Figure 26 was based on the peaks similar coupling constant, J 
[Hz]. There are five protons on the polymethine chain and twelve protons on the heterocyclic 
rings. The symmetrical nature of the dyes causes two equivalent of every proton except the pro-
ton of the center carbon and results nine distinct proton. 
 
Figure 26 proposed 1H labeling of 42b in DMSO-d6 
 
The quinoline is connected to the methine chain at 4 position, resulting in two doublets from one 
side of the ring (in blue) and a sets of both triplet and doublet, from the other side in red, as 
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shown in Figure 28. Following the molecular structure labeling in Figure 26, the two peak fur-
thest down-field have different coupling values, suggesting that they belong to different ring in 
the heterocycle. The first doublet at 8.36 ppm (J = 8.34 Hz) has a different coupling value from 
second doublet at 8.09 ppm (J = 7.07 Hz) has a coupling constant of. Another doublet at 7.32 
ppm (J = 7.07 Hz), also has a coupling constant and would belong to the heterocycle colored 
red A. The peaks at 7.95, 6.93, 6.63 have large coupling values (J >12 Hz) the integration of 
these three peaks corresponds to five protons of the methane bridge colored in green. The mul-
tiplet ranging from 7.78-7.87 ppm appear to be an overlap of a doublet and triplet and with an 
integration that would correspond to two protons colored red. The triplet at 7.53 would account 
for the foruth signal from the ring in red as it integrates to one proton on the red heterocyclic 
ring.  
7-  
Figure 27 Time-dependent UV-Vis Spectra of 36f in DMSO  
 
When you compare the two pentamethine dye systems, dyes 36f produces a very board ab-
sorbance spectra as shown in Figure 27. Strong self-aggregation tendency of polymethine cya-
nine dyes caused by Van der Waals forces and π-π conjugated system interaction.  In addition, 
the conjugated system will be broken due to autoxidation, resulting in abs bleach.  
In addition to this the dyes observes solvatochromic shifts, as shown in Table 4. For example 
when any of the dyes is present in methanol, solution is blue but in dichloromethane, the solu-
tion is green. This effect was not seen in the other set of dyes. After the characterization of the 
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dyes sets, the compounds were sent to Dr. Grant’s lab to be tested for photo-cleavage (PC) 
properties with pUC19 DNA from E.coli carried at physiological PH (7.4) and  temperature (37 
°C). 
Table 4 Photo physical properties of  dyes 35a-f. 
 
 
 
 
 
3.6 Results and Discussion 
For` DNA photosensitization, the absorption of light and the subsequent photochemical path-
ways are mediated by the interacting chromophore; with three main modes of complexation 
have been characterized for canonical B-DNA: (1) the groove binding (2) intercalation (3) inser-
tion. 59-61. For example, the grove binding interactions are stabilized by electrostatic interactions 
between the negatively charged backbone and cationic photosensitizers. In the case of ligand 
intercalation, the π-stacking interaction strongly compensates for the helical distortion in B-DNA 
helical structural. Aromatic ring system, such as that of cationic Ethidium bromide, can diffuse 
into the hydrophobic area between the two DNA base pairs. Lastly, if insertion is the mode inter-
face with DNA energy is offset by the non-Watson-Crick pairing, in which one sensitizer ejects 
one of the nucleo bases from take its place. The dyes screened are shown in Figure 29 with 
their respective photo-cleavage (PC) activity. In the study, dye 36f showing the most damage to 
the DNA, following by 42a and 42d. The dyes have the potential of interacting through grove 
binding to DNA due to the bent shape and charge of the dye. Intercalating would also be possi-
ble if one on the end terminals of the dyes where to diffuse between the two DNA base pairs. In 
each described case, the mode of interaction with the DNA and action of each dye could be dif-
ferent as the interactions modes are competitive and several of them may coexist. Additional 
Dye λabs in DCM (nm) λabs in MeOH 
(nm) 
ε(Lmol-1 cm-1 x 103)a 
35a 736 725 37.9 
35b NR 718 48.8 
35c NR 722 40.8 
35d 724 716 36.2 
35f 726 713 39.8 
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experiment need to be conducted to probe the mode of DNA-complexation, in order to identify 
how the triplet energy is transferred, either directly to DNA or to molecular oxygen.  
 
Figure 28 DNA Photo-oxidation Cleavage assay of select dyes, performed in triplicate; control = DNA and no dye 
 
Cont’    41   CMH-16   42b    42c     42f       42g     36     35a     35b     35f       42a   42d  42e 
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Reviewing the cleaving data in Figure 28, a general trend was observed for both sets pentame-
thine dyes in which the dyes with longer alkyl groups on the heteroatom of the ring, showed 
higher a cleaving activity when compared to same dye with a shorter chain. In addition, halogen 
substituent at the center of the pentamethine chain, decreased the PC activity, with the excep-
tion of 42g which has a longer chain (butyl) when compared to other dyes with halogen substitu-
tion. This stuggests that strics play an part in the cleaving activity. Furthermore, shortening the 
polymethine chain decreased the PC activity, as in the case of the trimethine dyes 36 and 41. 
The dye with the highest activity 35f, was then exposed to different reaction conditions further to 
investigate mode of induced cleavage. As shown in Figure 29 dye 35f showed that the induced 
cleavage was temperature dependent and is enhanced with the addition of biological metals 
such as, Fe3+ and Cu+2. 
 
Figure 29 Both exposed to minimal light A) Agarose Gel Electrophoresis of Temperature dependent study of 35c at 
10 μM with a reaction time of 24h; B) Agarose Gel  Electrophoresis of 35f at 10 μM with addition of [Fe
3+
] or  [Cu
2+
] 
at10 μM  with a reaction time of 24h at 37℃. 
 
However, during the experiments, dye 35f showed cleavage even when light exposure is mini-
mized (in dark). Due to the finding, an additional set of experiments was conducted by the Grant 
Lab were The cleavage was also observed was time dependent.as shown by Figure 30. Select-
ed fragments of the terminal phenanthridine showed no cleavage induced in the presence with 
DNA suggesting that the polymethine system is needed for PC activity. 
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Figure 30 Agarose Gel Electrophoresis of 35f and pUC19 DNA. Conditions 1.5 % agarose non-denaturing gel10 mM 
sodium phosphate buffer (pH 7), minimal light exposure, 24 hr reaction time. 
 
 
Figure 31 Selected fragments of the terminal  
 
Furthermore the dye still cleaves the plasmid DNA even with EDTA added to the reaction mix-
ture as show in Figure 31 suggesting that the dye alone is responsible for the PC.DNA binding 
can occur via three main ways, including intercalative, groove, and external binding modes. 
Stability of dye 35f in chelating agents improved the dyes stability in aqueous solutions as 
shown in Figure 33. Oxidation of the dye can occur is metal-complexation is formed in solution 
which would cause the dye to break down if oxidized by a metal.  
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Figure 32 Time dependent study of Dye 35f in various aqueous solution 
 
The negatively charged DNA surface should attract these electron deficient system which could 
then diffuse into the hydrophobic area, such as between the DNA base pairs. Such a change in 
environment of the chromophore would be observed via its UV-Vis spectra, as in the case of 
DNA stain EtBr. Nonetheless when trying to observe the dye--DNA interaction, the spectra for 
35f showed both absorption attenuation as a function of time in both sodium phosphate buffer 
and  DNA solutions, shown in Figure 34. The bleaching in UV-vis absorption could attribute its’ 
PC activity as  photo-bleaching is dependent upon the molecular structure and the local envi-
ronment 
.  
Figure 33Time-Course UV-Vis Absorption of 35f in 10 mM Sodium Phosphate Buffer 
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Figure 34 a. No Quencher b. Quencher—EDTA c. Quencher--Ethidium Bromide ; N (Nicked) , L (Linear) , S (Super-
coiled); Dark Control (DC) Blank (B) 
 
In contrast, either triemthime dyes 36 or 41 containing the heterocycle as shown in Figure 35, 
which need a light source to induce cleavage  
 
• Figure 35 Photocleavage Experiment at 700 nm for  31 (ESS-36) and CMH-16 at10 μM of in 38 μM bp 
pUC19 DNA, 10 mM Na3PO4 buffer pH 7.0. 
 
 
Dye 36 in the presence of DNA has a red shift to λmax to about 600 nm and dye 41 exhibited hy-
pochromic and bathochromic shifts in the presence of CT DNA with a λmax at around 710 nm. As 
shown in Figure 37  
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Figure 36 UV-Vis of dye 36 (left) and CMH-16 (right) with DNA at 10 uM 
 
3.7 Conclusion 
The dyes were synthesized in good yield. The phenanthridine and quinoline core provide 
interaction with pDNA that induced cleavage when with light (35f). Utilizing 4-methylquinoline 
allowed the both tri- and penta-methine dyes to absorb at longer wavelength and still maintained 
the in PC activity for DNA in comparison to the other cyanine dyes synthesized. This suggests 
that the photocleavge activity is dependent on the structure of the dyes and thus would allow the 
development for a dyes system with ideal photo physical properties to be further developed as 
PDT agents. Future Direction allow for modifications that will facilitate tumor cell selectivity and 
specific subcellular localization of the PDT agents that could be individually fine-tuned for an 
exact therapeutic requirement. 
3.8 Experimental for Chapter 2: Pentamethine Dyes 
Synthesis of N-([1,1'-biphenyl]-2-yl)acetamide 32 
64.0 mmol (10.3 g) of [1,1'-biphenyl]-2-amine was added to 60 mL of acetic anhydride (Ac2O) 
(10 eq) and stirred for 2 h at room temperature. Upon cooling the solution to room temperature, 
the solution was poured over in ice bath to precipitate out 32 as an egg shade/off white solid. 
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The product was collected under vaco. and washed with deionized water. The solid was then 
dried under vaco. and was used as in latter  steps. The reaction was monitored via thin layer 
chromatography (TLC) using dichloromethane (DCM) as the eluting solution. 13.0 g Yield 96 % 
Synthesis of 6-methylphenanthridine 33 
62.0 mmol (13 g) was refluxed in 45 mL of phosphoryl chloride (POCl3) (7 eq) for 3.75 h under 
nitrogen. Upon cooling the solution to room temperature, the solution was poured over in ice 
bath to precipitate the salt of 33 as an off-white solid. The solid was collected under vaco. and 
was washed with deionized water. The solid was then added to a concentrated solution of sodi-
um carbonate (Na2CO3) and extracted twice with 50 mL DCM. The organic layers were then 
concentrated using a rotary evaporator to afford 33 as a dull orange solid. 
Yield 76 %, 9 g; 1H NMR (400 MHz, DMSO-d6): δ ppm 3.31 (s, 3H), 7.97-8.09 (m, 3H), 8.22 (d, 
J = 8.0 Hz, 1H), 8.33 (t, J = 13.2Hz, 1H), 8.71 (d, J = 8.4 Hz, 1H), 9.03 (d, J = 8.0 Hz, 1H), 9.09 
(d, J = 8.4 Hz, 1H) ; 13C NMR (100 MHz, DMSO-d6): 19.09, 123.44, 123.73 
General Synthetic Procedure for the phenanthridinium salts 
10 mmol (2.0 g) of 15 was heated in the appropriate alkyl halide for 3 days in a sealed tube. The 
reaction was monitored via TLC using DCM as the eluting solution. Upon cooling to room tem-
perature, the solution was added diethyl ether to precipitate out the salt. The solid was the col-
lected under vaco. and washed with diethyl ether and acetone. The salt 4c was used without 
further purification in subsequent reactions. 
5,6-dimethylphenanthridin-5-ium iodide 34a; yellow solid, Yield 72 %;1H NMR (400 MHz, 
DMSO-d6): δ ppm 3.58 (s, 3H), 4.58 (s, 3H), 8.04-8.13 (m, 3H), 8.35 (t, J = 8.0 Hz, 1H), 8.64 (d, 
J = 8.4 Hz, 1H), 8.92 (d, J = 8.4 Hz, 1H), 9.15 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz, DMSO-
d6): δ ppm 19.17, 40.87, 119.60, 122.91, 123.93, 124.02, 129.12, 129.73, 130.19, 131.23, 
132.65, 134.52, 136.34, 165.44 m.p. > 260 °C 
5-ethyl-6-methylphenanthridin-5-ium iodide 34b; yellow solid, Yield 62 %; 1H NMR (400 
MHz, CDCl3-d): δ ppm 1.63 (t, J=7.08 Hz, 3 H) 3.47 (s, 3 H) 5.13 (d, J=7.17 Hz, 2 H) 8.01 - 8.15 
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(m, 3 H) 8.34 (t, J=7.77 Hz, 1 H) 8.64 (d, J=8.70 Hz, 1 H) 8.91 (d, J=8.19 Hz, 1 H) 9.14 (t, 
J=8.88 Hz, 2 H) 
34c 5-butyl-6-methylphenanthridin-5-ium iodide yellow solid, Yield 68%, 1H NMR (400 MHz, 
CHLOROFORM-d) d ppm 1.13 (t, J=7.34 Hz, 3 H), 1.80 (d, J=7.34 Hz, 2 H), 2.05 - 2.28 (m, 2 
H), 3.81 (s, 3 H), 5.33 (d, J=6.66 Hz, 2 H), 7.98 - 8.09 (m, 3 H), 8.25 (t, J=8.02 Hz, 1 H), 8.38 (d, 
J=9.05 Hz, 1 H), 8.77 (d, J=8.53 Hz, 1 H), 8.81 - 8.89 (m, 2 H) 
General Synthetic Procedure for 34a-e 
At a ratio of 2:1, 2 mmol of the appropriate salt 15a-c to the polymethine regent, ((E)-N-((E)-3-
(phenylamino)allylidene)benzenaminium chloride were dissolved in 5 mL of Ac2O. To this solu-
tion, 2 mol. eq. of triethylamine (TEA) was added. The reaction mixture was heated to 75 °C. 
The reaction was monitored via UV-VIs. After the reaction was completed, ethyl ether was add-
ed to afford the dyes. 
The dyes were purified via column chromatography solvent ratio of 1:25 methanol to methylene 
chloride. 
5-methyl-6-((1E,3E,5E)-5-(5-methylphenanthridin-6(5H)-ylidene)penta-1,3-dien-1-
yl)phenanthridin-5-ium iodide 35a; dark purple solid, Yield 25 % 1H NMR (400 MHz, DMSO-
d6): δ ppm 4.10 (s, 6H), 6.79 (t, J = 8.8 Hz, 1H), 6.91 (d, J = 13.6, 2H), 7.76-7.62 (m, 4H), 7.77 
(q, J = 6.4, 4H). 7.88 (d, J = 9.2 Hz, 2H), 7.94 (t. J = 8.0 Hz, 2H), 8.36 (d, J = 7.6 Hz, 2H) 8.61-
8.68 (m, 4H); 13C NMR (100 MHz, DMSO-d6): δ ppm 41.55, 108.96, 117.11, 121.70, 122.54, 
123.07, 125.65, 126.20, 128.00, 128.62, 130.30, 131.14, 132.50, 137.65, 147.99, 153.12; λmax in 
MeOH = 714 nm; m.p. = 176-178 °C 
6-((1E,3Z,5E)-3-chloro-5-(5-methylphenanthridin-6(5H)-ylidene)penta-1,3-dien-1-yl)-5-
methylphenanthridin-5-ium iodide 35b; Yield 46 % 1H NMR (DMSO-d6 ,400 MHz): δ ppm 
4.16 (s, 6 H) 6.90 (d, J = 13.39 Hz, 2 H) 7.64 (t, J = 7.71 Hz, 2 H) 7.74 - 7.85 (m, 6 H) 7.93 - 
8.04 (m, 4 H) 8.36 (d, J = 8.08 Hz, 2 H) 8.69 (d, J = 8.34 Hz, 2 H) 8.74 (d, J = 7.83 Hz, 2 H) ; 
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13C NMR (DMSO-d6 ,100 MHz): δ ppm 42.25, 105.53, 118.02,122.23, 122.37, 123.15, 123.7, 
125.79, 126.23, 128.77,129.46, 131.00, 131.84, 133.55, 137.65, 143.98, 155.15 
5-ethyl-6-((1E,3E,5E)-5-(5-ethylphenanthridin-6(5H)-ylidene)penta-1,3-dien-1-
yl)phenanthridin-5-ium iodide 53c; dark green solid, 19 %;  1H NMR (400 MHz, DMSO-d6): δ 
ppm 1.47 (t, J = 6.8 Hz, 6H), 4.61 (q, J = 7.2 Hz, 4H), 6.74 (d, J = 14.0 Hz, 2H), 6.84 (t, J = 13.2 
Hz, 1H), 7.47-7.57 (m, 4H), 7.75 (q, J = 7.2 Hz, 4H) 7.92-7.97 (m, 4H), 8.23 (d, J = 8.0 Hz, 2H), 
8.64 (t, J = 7.2 Hz, 4H);13C NMR (100 MHz, DMSO-d6): δ ppm 12.29, 45.67, 108.98, 116.89, 
122.03, 122.38, 123.44, 124.49, 125.65, 125.89, 128.44, 129.73, 130.48, 132.66, 135.68, 
147.99, 152.68, λmax in MeOH = 712 nm; mp = 185 °C decomp. 
6-((1E,3Z)-3-chloro-5-((E)-5-ethylphenanthridin-6(5H)-ylidene)penta-1,3-dien-1-yl)-5-
ethylphenanthridin-5-ium iodide 35d 1H NMR (400 MHz, DMSO-d6) δ ppm 1.54 (br. s., 7 H), 
4.68 (d, J=5.56 Hz, 4 H), 6.74 (d, J=13.64 Hz, 2 H), 7.62 (br. s., 2 H), 7.71 - 7.88 (m, 7 H), 8.02 
(t, J=7.96 Hz, 4 H), 8.28 (d, J=8.08 Hz, 2 H), 8.72 (br. s., 4 H);13C NMR (100 MHz, DMSO-d6) δ 
ppm 12.99, 46.94, 105.77, 118.13, 123.41, 124.51, 131.31, 131.71, 132.93,134.20, 136.12, 
144.99,  
6-((1E,3Z)-3-bromo-5-((E)-5-ethylphenanthridin-6(5H)-ylidene)penta-1,3-dien-1-yl)-5-
ethylphenanthridin-5-ium iodide 35e1H NMR (400 MHz, DMSO-d6) δ ppm 1.55 (t, J = 6.82 
Hz, 6 H) 4.66 (d, J = 7.07 Hz, 4 H) 6.72 (d, J = 13.14 Hz, 2 H) 7.62 (t, J=7.58 Hz, 2 H) 7.71 - 
7.84 (m, 6 H) 7.96 - 8.05 (m, 4 H) 8.26 (d, J=8.08 Hz, 2 H) 8.71 (t, J = 6.82 Hz, 4 H) 
5-butyl-6-((1E,3E,5E)-5-(5-butylphenanthridin-6(5H)-ylidene)penta-1,3-dien-1-
yl)phenanthridin-5-ium iodide 35f; dark purple solid, Yield 29 %1H NMR (400 MHz, DMSO-
d6): δ ppm 0.94 (t, J = 7.2 Hz, 6H), 1.43 (m, J = 8 Hz, 4H), 1.81 (m, J = 6 Hz, 4H) 4.54 (t, J = 7.6 
Hz, 4H), 6.75 (d, J = 13.2 Hz, 2H), 6.82 (t, J = 12.8, 1H),  7.46 (t, J = 12.8, 2H), 7.45 (t, J = 7.6, 
2H), 7.74 (q, J = 7.6 Hz, 4H),7.89-7.96 (m, 4H), 8.22 (d, J = 8.0 Hz, 2H), 8.62 (t, J = 8.0 Hz, 4H); 
13C NMR (100 MHz, DMSO-d6): δ ppm 13.06, 18.73, 28.57, 50.81, 109.55, 117.10, 117.19, 
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122.19, 122.39, 123.45, 124.53, 125.81, 125.95, 128.33, 128.49, 129.25, 130.37, 131.59, 
132.62, 135.99, 147.43, 153.17; λmax = 710 nm; mp = 187 °C decomp 
 
1-methyl-4-((1E,3E)-5-((Z)-1-methylquinolin-4(1H)-ylidene)penta-1,3-dien-1-yl)quinolin-1-
ium iodide 42a 1H NMR (400 MHz, DMSO-d6) δ ppm 3.97 (s, 6 H) 6.65 (t, J=12.25 Hz, 1 H) 
6.99 (d, J=13.39 Hz, 2 H) 7.32 (d, J=7.33 Hz, 2 H) 7.59 (t, J=7.07 Hz, 2 H) 7.78 - 7.89 (m, 4 H) 
7.95 (t, J=13.01 Hz, 2 H) 8.09 (d, J=7.07 Hz, 2 H) 8.42 (d, J=8.34 Hz, 2 H); 13C NMR (100 
MHz, DMSO-d6) δ 41.96, 108.27, 110.97, 117.78, 119.40, 124.70, 125.27, 126.44, 129.11, 
133.00, 139.42, 141.95, 147.44 
4-((1E,3Z)-3-chloro-5-((Z)-1-methylquinolin-4(1H)-ylidene)penta-1,3-dien-1-yl)-1-
methylquinolin-1-ium iodide 42b  
1H NMR (400 MHz, DMSO-d6) δ ppm 4.05 (s, 6 H) 6.94 (d, J=13.14 Hz, 2 H) 7.41 (d, J=7.33 Hz, 
2 H) 7.67 (t, J=5.81 Hz, 2 H) 7.86 - 7.97 (m, 4 H) 8.14 (d, J=12.88 Hz, 2 H) 8.30 (d, J=7.07 Hz, 
2 H) 8.41 (d, J=8.34 Hz, 2 H) 
1-ethyl-4-((1E,3E)-5-((Z)-1-ethylquinolin-4(1H)-ylidene)penta-1,3-dien-1-yl)quinolin-1-ium 
iodide 42d 1H NMR (400 MHz, DMSO-d6) δ ppm 1.38 (t, J = 7.07 Hz, 6 H) 4.40 (q, J = 6.99 Hz, 
4 H) 6.63 (t, J = 12.38 Hz, 1 H) 6.93 (d, J = 13.39 Hz, 2 H) 7.31 (d, J = 7.07 Hz, 2 H) 7.53 (t, J = 
7.45 Hz, 2 H) 7.75-7.88 (m, 4 H) 7.95 (t, J = 12.88 Hz, 2 H) 8.09 (d, J = 7.07 Hz, 2 H) 8.36 (d, J 
= 8.34 Hz, 2 H) 13C NMR (100 MHz, DMSO-d6): δ ppm 14.91, 48.91, 108.73, 111.02, 117.47, 
124.90, 125.57, 126.22, 133.01, 138.16, 140.79, 147.39 
 
4-((1E,3Z)-3-chloro-5-((Z)-1-ethylquinolin-4(1H)-ylidene)penta-1,3-dien-1-yl)-1-
ethylquinolin-1-ium iodide 42e 11H NMR (400 MHz, DMSO-d6) δ ppm 1.44 (t, J = 6.57 Hz, 
6 H) 4.51 (d, J = 6.82 Hz, 4 H) 6.93 (d, J = 12.88 Hz, 2 H) 7.65 (t, J = 7.33 Hz, 2 H) 7.84 - 7.93 
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(m, 2 H) 7.99 (d, J = 8.59 Hz, 2 H) 8.16 (d, J = 13.14 Hz, 2 H) 8.34 (d, J = 6.82 Hz, 2 H) 8.40 (d, 
J = 8.08 Hz, 2 H) 
 
4-((1E,3Z)-3-chloro-5-((Z)-1-butylquinolin-4(1H)-ylidene)penta-1,3-dien-1-yl)-1-
butylquinolin-1-ium iodide 42f 1H NMR (400 MHz, DMSO-d6) δ ppm 0.93 (br. s., 6 H) 1.37 
(br. s., 4 H) 1.80 (br. s., 4 H) 4.47 (br. s., 5 H) 6.95 (d, J = 11.62 Hz, 2 H) 7.44 (br. s., 2 H) 7.66 
(br. s., 2 H) 7.91 (br. s., 2 H) 7.99 (br. s., 2 H) 8.15 (d, J = 12.88 Hz, 2 H) 8.32 (br. s., 2 H) 8.42 
(br. s., 3 H);13C NMR (100 MHz, DMSO-d6) δ ppm 14.01, 19.75, 31.27, 54.02, 106.68, 109.33, 
118.14, 122.71, 125.00, 125.53, 127.02, 133.52, 138.30,141.50,142.47, 148.60   
 
4-((1E,3Z)-3-bromo-5-((Z)-1-butylquinolin-4(1H)-ylidene)penta-1,3-dien-1-yl)-1-
butylquinolin-1-ium iodide 42g  
1H NMR (400 MHz, DMSO-d6) δ ppm 0.93 (br. s., 6 H) 1.38 (d, J=5.81 Hz, 4 H) 1.80 (br. s., 4 H) 
4.48 (br. s., 4 H) 6.92 (d, J = 12.38 Hz, 2 H) 7.46 (br. s., 2 H) 7.67 (br. s., 2 H) 7.92 (br. s., 2 H) 
8.00 (br. s., 2 H) 8.25 (d, J = 12.88 Hz, 2 H) 8.36 (br. s., 4 H); 13C NMR (100 MHz, DMSO-d6) δ 
ppm 14.01, 19.75, 31.28, 54.02, 106.68, 109.33, 118.13, 122.71, 125.00, 125.53, 127.02, 
133.52, 138.30, 141.50, 142.47, 148.60  
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4 Synthesis and Evaluation of Novel Near-Infrared Phenoxazinium Dyes as Potential Contrast 
Agents for Imaging Insulinoma  
This chapter includes the synthesis of near-infrared phenoxazinium dyes as potential as con-
trast agents for insulinoma.  
4.1 Summary of Insulinoma, a Pancreatic Cancer 
 
Figure 37 The pancreas  
 
The pancreas is both an endocrine gland and part of the digestive system, thus containing two 
different types of glands: exocrine and endocrine, as shown in Figure 37. The endocrine pan-
creas gland contains four types of cells, with each responsible for the hormone secretion of glu-
cagon, pancreatic polypeptide, somatostatin, and insulin respectively. The exocrine pancreas 
gland contains two types of cells, which release pancreatic juices with digestive enzymes to aid 
in digestion and absorption of nutrients. Due to the many functional cell types of the pancreas, 
cancer of the pancreas can have two manifestations, functioning and nonfunctioning62. In 2012 
alone, pancreatic cancers caused more than 330,000 deaths globally and an estimated 48,000 
new cases are expected to occur in the US in 201563,64. Nonfunctioning tumors may cause ob-
structive symptoms of the biliary tract or duodenum, bleeding into the GI tract, or abdominal 
masses. Functioning tumors hypersecrete a particular hormone, causing various syndromes. 
Neuroendocrine tumors of the pancreas and duodenum include gastrinomas, vasoactive intesti-
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nal peptideoma (VIPomas), somatostatinomas (SST), and insulinomas, with the latter account-
ing for 17% of all cases62,65-67. Insulinoma, the most frequent form of pancreatic neuroendocrine 
tumors of β-cell origin and although only 10% of insulinomas are malignant, all cause hyperinsu-
linemic hypoglycemia (low blood glucose caused by excessive insulin 68,69. Diagnosis of insu-
linoma is defined clinical parameters derived from the Whipple triad, hypoglycemia symptoms in 
the presence of low plasma glucose with clinical relief on glucose administration68,69. As almost 
all (97%) insulinoma are located in the pancreas, few methods provide specific contrast in-
traoperatively as only 80% of insulinoma are single with localization of tumors less than 2 cm 
remaining difficult using a single imaging technique 52,62,67,70-74,. During suergy, it is very im-
portant to distinguish between cancerous and healthy tissues in real-time with high sensitivity \ 
to avoid such injury to other organs. If tumors not effectively identified, incomplete or blind re-
section and/or the need for re-exploration can result in clinical syndromes leading to multiple 
endocrine neoplasia, in which tumors or hyperplasia affects additional endocrine glands75.  
With the current limit of detection, diagnosis of the cancer has usually either had spread 
throughout the body or has fully developed thus rendering treatment ineffective, with surgical 
removal of the tumor is the treatment of choice for insulinoma 63,70,75. Furthermore, there is a 
need to develop better imagine techniques to assist in identify the cancer at various stages and 
during surgery. An ideal method for detection for insulinoma cancer would be noninvasive with 
minimal side effects to the patient and a low limit of detection which would for allow early detec-
tion.  
4.2 Rational of NIR Fluorophore 
Medical Imagining is limited to the optical window which is defined as the range of wavelengths 
between NIR 650 - 900 nm where light has its maximum depth of penetration in tissue and min-
imal interference from native biological tissues and molecules, as shown in Figure 38. 
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Figure 38 Optical window on in vivo bio imaging 
Near-infrared (NIR) fluorescence imaging is a promising technique to facilitate intraoperative, 
real time, visual identification of tumors76-78.  Although several near-infrared (NIR) fluorophores 
have shown promise in preclinical model systems, there are no tumor-specific contrast agents 
presently available for clinical use. In fact, the only 2 NIR fluorescent contrast agents that are 
available clinically and approved, the 700 nm fluorophore methylene blue (MB) and 800 nm 
fluorophore indocyanine  green (ICG), as shown in Figure 39. Furthermore MB and ICG have 
been clinically used for decade yet both agents are classified as non-specific with respect to 
targeting.  
 
Figure 39 FDA approved NIR fluorescent probes 
 
The combination of a NIR fluorescent contrast agent and appropriate imaging system could help 
the surgeon localize the desired disease, to define the boundaries of vital ograns to find small 
occult metastases within the surgical field79. The ideal fluorophore for the optical imaging would 
have properties that allows aqueous solubility, large Stokes shifts, large extinction coefficient 
(ε>50,000 M-1 mol) long emission wavelength (ʎ >680 nm), and high quantum yield (Φ). The 
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long wavelength would allow for less light scattering and deeper penetration since the pancreas 
is located behind the stomach, shown in Figure 40.  
 
Figure 40 Anatomy of the pancreas, taken without permission 
Recently MB has shown uptake in the pancreas and localization in cancerous tissues and alt-
hough MB does provided contrast between the pancreas and surrounding organs, it is not an 
ideal NIR contrast agent because of low signal intensity, nonspecific uptake, and short retention 
time in the pancreas62,70,71,80-83. Thus the synthesized fluorophore would utilize a three ring sys-
tem as a base, as shown in Figure 41; when X is a nitrogen, oxygen, or sulfur the molecule 
would be phenazine, phenoxazine, and phenothiazine respectively with the aminos acting as a 
donor/acceptor group for tailoring the absorbance and emission bands.  
 
Figure 41 Design of compact NIR contrast agent 
From the literature, there a trend in which there is an increase in both absorbance and fluores-
cence maxima with the heteroatom increasing down the same group. Phenothiazine ( X = S)  
based dyes, such as methylene blue (MB) provides both absorbance and fluorescence within 
the NIR window (660-690 nm) but, are well studied for their production of 1O2 which limits it use 
an imaging agent50,84,85. Phenazine ( X = N) based dyes have both absorbance and fluores-
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cence bands within the yellow region (540-580 nm), thus having too short of wavelength maxi-
ma that would allow good contrast and not in the NIR window86. Phenoxazine ( X = O) based 
dyes have both absorbance and fluorescence bands within the blue region (620-670 nm), mak-
ing it a sutable scaffold to explore as possible imaging agents. Although Nile blue derivatives 
(benz[c]phenoxazine) provide additional conjugation that shift both fluorescence band, the lipo-
philicity of the dyes increases with organic content (, i.e. alkyl, aryl,) limiting its solubility in a po-
lar media such as water. The donor groups on the nitrogen would shift the phenoxzine dye to 
longer wavelengths and Increase the stoke shifts would further minimize interference from the 
excitation source and minize background interface87. Furthermore, through our collaborators at 
Beth Israel Deaconess Medical Center and Harvard Medical School, a preliminary of commer-
cial available oxazine dyes were evaluated but synthesis of these dye have not been reported.  
4.3 Syntheisis of Symmetrical and Unsymmetrical Phenoxazinium Dyes 
Although Nile Blue (benz[a]phenoxazinium) derivatives with secondary amine have been re-
ported, the literature lacks of pheonaxine dyes with secondary amines is not reported88-90. The 
synthesis of phenoxazinium 49 and 50, as shown in Equation 9 is prepared from the condensa-
tion of a nitroso anisole 44 with aminophenol derivatives 47 or 48 in acidic medium under reflux.  
 
Equation 5 Synthesis of phenoxazinium dye 
 
The first half of the dye begins with the formation of the nitroso compounds 43, as shown in 
Scheme 9 from m-anisole. 
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Scheme 9 Synthesis of Alkylated 4-Nitroso-3-aminoanisole  
 
The animo of the m-anisole was alkylated in basic conditions with the appropriate alkyl halide at. 
Under these basic conditions, mono-, di-, and tri alkylation of the amine occurred as shown by 
TLC. As such, flash column chromatography was used to isolate the di- and mono-alkylated an-
isoles 43a-b. After isolation, nitrosylation of the anisole was achieved with a solution of sodium 
nitrate (NaNO2) and hydrochloric acid in water. When the reaction was completed, neutralizing 
the reaction mixture precipitated, the dialkylated anisole nitroso compounds out of aqueous so-
lution. In contrast, the monoalkylated anisole was extracted with ethyl acetate from the aqueous 
reaction due to it forming an oil upon neutralizing the reaction mixture. 
To alter the hydrophobicity of the overall dye, the second half of the dye was obtain from either 
4-methyl-3nitro-2-phenol 45 or m-phenol, shown in Scheme 10.  
 
 
Scheme 10 Synthesis of Alkylated Aminophenol 
The nitro compound 45 was reduced using Pd/C in methanol with ammonia formate 
(NH4●HCO2).The animophenols were alkylated in basic conditions with the appropriate alkyl 
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halide. Under these basic conditions, mono-, di-, and tri alkylation of the amine occurred as 
shown by TLC. As such, flash column chromatography was used to isolate the di- and mono-
alkylated aminophneols 47-48a-b. 
 
Scheme 11 Syntheisis of Symmetrical and Unsymmetrical Phenoxazinium Dyes 
 
After isolation of the respective halves, a mixture of the phenol 47 and nitroso compound 44 
with the appropriate acid were slowly heated to reflux, with color change in the solution occur-
ring with the first four hours of the initial heating and mixing. The reaction was monitored via UV-
Vis until there was no change in its absorption spectra by following the decrease in absorption 
of the starting materials and increase in absorption of the dye 49/50. After heating, the reaction 
mixture was cooled and concentrated under reduced pressure. The dark residue was then dis-
solved in a mixture of 1:1 methanol: acetone and was loaded on the column. The dye eluted 
using a gradient mobile phase composed of acetone and methanol. Chloroform was omitted as 
a mobile phase due to acetone providing better solubility of concentrated residue. After concen-
trating the dark blue fractions from the column, they were concentrated under reduced pressure 
and with minimal methanol (approx. 2 ml) present in the flask a 1:1 diethyl ether: ethyl acetate 
solution was added to precipitate the dyes as dark blue solids. The dye was collected under re-
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duced pressure and recrystallized from acetone in ethyl acetate to achieve a high purity sample 
for NMR analysis. 
4.3.1.1 Computational methods 
The Calculated LUMO and HOMO orbitals where obtained  using a restricted hybrid HF-DFT 
SCF calculation performed using Pulay DIIS + Geometric Direct Minimization and 6-31G* basis 
set , B3LYP Method via Spartan or Gassuioin(03). 
 
4.4 Characterization 
Compound 49a was chosen as a representative for complete chemical characterization and 
analysis via NMR (13C and 1H). The 1H spectra of 49a are shown in Figure 43 in CD3OD-d4. 
Analyzing the dye structure of 49a, the symmetrical nature of the dyes allows the dye to have 
four signals in the 1H spectra, as shown in Figure 43. 
 
Figure 42 
1
H NMR spectrum of 49a in CD3OD-d4 at 25°C  
 
The spectra of 49a show three peaks in the aromatic region consisting of two doublets (J = 7.10 
Hz) and a singlet, which agrees with both the integration and expected splitting patter of the dye 
molecule. Furthermore, a singlet appears in the aliphatic region, which is expected from the di-
methyl of the amines. The 13C spectra of 49a are shown in Figure 44 in CD3OD-d4. The 
13C 
    69 
spectrum of 49a shows all seven expected signals from the dye molecule. In the aromatic re-
gion, the two peaks furthest downfield would correspond to the carbons connected directly to 
the heteroatom of the tricyclic ring system.  
 
Figure 43 NMR spectrum of 49a in CD3OD-d4 at 25°C 
 
The carbon connected to the alkylated amines would appear further up field when compared to 
the other aromatic peaks due to the electron donating nature of the amino group. Also a single 
peak appears in the aliphatic region, which is expected from the dimethyl of the amine. 
When the symmetry of the dye is altered, a more complex spectra is observed due to more sig-
nals as shown in Figure 45. 
 
Figure 44 Top: 
1
H NMR spectrum of 49a in CD3OD-d4 at 25°C; Bottom: 
1
H NMR spectrum of 49c in bottom CD3SO-d6 
at 25°C 
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4.5 Results and Discussion  
 
Scheme 12 Syntheisis of Symmetrical and Unsymmetrical Phenoxazinium Dyes 
 
For the synthesis of 3,7-bis(dialkylamino)phenoxaziniums, the use of starting material with sec-
ondary amines, specify the monoalkylated-nitrosoanisoles, required perchloric acid for the reac-
tion to proceed as shown in Scheme 12. The physical properties for the dyes 49a-d,50 where 
calculated using ChemAxon( Budapest, Hungry) are found in Table 5. 
 
Table 5 The physical properties for the dyes 49a-e,50  where calculated using ChemAxon( Budapest, Hungry) 
 
Both MB and dye 49a have similar physical properties but observe different photo-physical 
properties as shown in Figure 46. 
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Figure 45 Optical Properties of Phenoxazinium Dyes 
 
The longer fluorescence lifetime and higher quantanm yield would provide sharper contrast 
when compared to MB. Through our collaborators at Beth Israel Deaconess Medical Center and 
Harvard Medical School, the biodistribution 3 for Dye 49a is shown in Figure 47.The imaging 
data shows different stages of the insulomia cancer as characterized by the size of the tumor as 
shown in Figure 47. Pancreatic cancer has three stages: Hyperplasia, Angiogenic, and Insu-
linoma in which they differ in vascularization, the formation of blood vessels and capillaries 
around the pancreatic islet. Stage one, Hyperplasia, has normal pancreatic islet cell vascula-
ture. Furthermore, the contrast as a ratio of Insulinoma to pancreas of dye 49a when compared 
to MB. Specify of the dye towards Insulinoma was shown on Figure 48 which shows MRI track-
ing and Co-registration of dye 49a. 
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Figure 46 Imaging Properties of Phenoxazinium Dye 49a  
 
 
 
Figure 47 MRI tracking and Co-registration of dye 49a  
4.6 Conclusion 
Six novel symmetrical and unsymmetrical Phenoxazinium dyes were synthesized in moderate 
yield (7-50 %). The dye 49a showed better selectivity for Insulinoma when compared to MB. 
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Enabling this technology with recent advancements in real time intraoperative imaging systems 
would allow for real-time localization of Insulinoma for the surgeon. 
4.7 Experimental  
Synthesis of 3-methoxy-N,N-dialkyllaniline 43a and 3-methoxy-N-alkylylaniline 43b 
A mixture of m-anisole (49 mmol), potassium carbonate (3 mol. eq.) in DMF (40 ml) was 
stirred at RT for 0.5 h. After stirring, iodomethane (2 mol. eq.) was added drop wise. After the 
addition, the mixurte was heated to 50o C for 18 h. After the mixture cooled, DI water was added 
and compounds 43a and 43b were extracted three times with 75 mL with ethyl acetate. The 
fractions were then concentrated and loaded on silica for purification via column chromatog-
raphy using a gradient solvent system of hexanes and ethyl acetate. 
3-methoxy-N,N-dimethylaniline 43a Yield 51 %; 1H NMR (400 MHz, CDCl3-d): δ ppm 
3.02 (s, 6 H) 3.89 (s, 3 H) 6.35 - 6.42 (m, 2 H) 6.44 - 6.50 (m, 1 H) 7.25 (t, J = 7.96 Hz, 1 H) 
3-methoxy-N-methylaniline 43b Yield 28 %; 1H NMR (400 MHz, CDCl3-d) δ ppm 2.87 
(s, 3 H) 3.84 (s, 3 H) 6.17 - 6.25 (m, 1 H) 6.30 (dd, J = 8.00, 0.90 Hz, 1 H) 6.35 (dd, J = 8.10, 
1.10 Hz, 1 H) 7.16 (t, J = 8.08 Hz, 1 H) 
Synthesis of 3-methoxy-N,N-dimethyl-4-nitrosoaniline 44a 
A mixture of compound 43a (26 mmol) and HCl (1.2 mol. eq.) in H2O (30 ml) was stirred 
in an ice bath. NaNO2 (1 mol. eq.) was slowly added to the mixture dropwise for 60 min and 
then the resulting mixture was stirred in ice bath for another 1 h. After addition of K2CO3 powder 
to basicify the above solution until pH ∼9, the mixture was filtrated and the green mass was 
washed with water. The mass was ultrasonicated in Et2O and filtrated to give nitroso compound 
44a. Yield 81 % 1H NMR (400 MHz, CDCl3-d) δ ppm 3.15 (s, 6 H) 4.14 (s, 3 H) 6.01 - 6.17 (m, 2 
H) 6.65 (d, J = 8.34 Hz, 1 H): 13C NMR (100 MHz, CDCl3-d) δ ppm 40.61, 56.16, 92.28, 104.18, 
156.10, 157.86 
Synthesis of 3-methoxy-N-methyl-4-nitrosoaniline 44b 
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A mixture of compound 43a (.9 g, 6.56 mmol) and HCl (1.2 mol. eq.) in H2O (30 ml) was 
stirred in an ice bath. NaNO2 (1 mol. eq.) was slowly added to the mixture dropwise for 60 min 
and then the resulting mixture was stirred in ice bath for another 1 h. After addition of K2CO3 
powder to basicify the above solution until pH ∼9, the mixture was added to 300 ml of DI water 
and washed 3x 75 mL of ethyl acetate. The organic layers were dried of magnesium sulfate and 
concentrated to give the nitroso compound 44b as oil. (1 g, 6.02 mmol, 81 % yield) 1H NMR 
(400 MHz, CDCl3-d) δ ppm 3.15 (s, 6 H) 4.14 (s, 3 H) 6.01 - 6.17 (m, 2 H) 6.65 (d, J = 8.34 Hz, 
1 H): 13C NMR (100 MHz, CDCl3-d) δ ppm 40.61, 56.16, 92.28, 104.18, 156.10, 157.86 
Synthesis of 3-amino-4-methylphenol 46 
Ammonium formate (15 g, 238 mmol) was dissolved in 50 ml MeOH and added to 50 ml 
of MeOH containng 3-amino-4-methylphenol (10.5 g, 68 mmol). To the solution, approx. 1 g of 
Pd/C was added and heated to 60 °C. The . Rxn was mointoired via TLC (4:1 HEX:EYLAc) 
showed completion after 18 h. The reaction mixture filtered via vaco and the mother liquid was  
concentrated. The resiude was then washed with 400 ml of DI water and extracted with 3x 75 ml 
of EtOAc. Yield 89 % 1H NMR (400 MHz, CDCl3-d ): δ ppm 2.10 (s, 3 H) 6.10 - 6.26 (m, 6 H) 
6.89 (d, J=7.58 Hz, 1 H) 
3-(N-methylamino)-4-methylphenol  47a Yield 42 %    1H NMR (400 MHz, CDCl3-d ): δ ppm 
2.08 (s, 3 H), 2.85 (s, 3 H), 6.15 (s, 2H), 6.90 (d, J = 7.6 Hz, 1 H) 
3-(dimethylamino)-4-methylphenol Yield 57 %  47b 1H NMR (400 MHz, CDCl3-d ): δ ppm 
2.26 (s, 3 H), 2.69 (s, 6 H), 6.44 (dd, J = 6.0  Hz, J = 2.4 Hz, 1 H), 6.55 (d, J = 2.0 Hz, 1 H) 7.01 
(d, J = 8.0 Hz, 1 H) ); 13C NMR (100 MHz, CDCl3-d): δ ppm 17.71, 44.04, 105.90, 109.08, 
123.72, 131.81, 153.69, 154.28 
Synthesis of 3-(dimethylamino)phenol 48a and 3-(methylamino)phenol 48b 
A mixture of compound m-aminophenol (93 mmol) and potassium carbonate (3 mol. eq.) 
in DMF (40 ml) was stirred at RT for 1h. After stirring, iodomethane (2 mol. eq.) was added drop 
wise. After the complete addition, the mixture was heated to 40o C for 3 h. After the mixture 
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cooled, DI water was added and compounds were extracted three times with 100 ml with ethyl 
acetate. The fractions were concentered and was purified via column chromatography using a 
gradient solvent system of hexanes and with ethyl acetate. 
3-(dimethylamino)phenol 48a Yield 38 % 1H NMR (400 MHz, CDCl3-d ): δ ppm 2.91 (s, 6 H) 
6.21 - 6.30 (m, 2 H) 6.36 - 6.44 (m, 1 H) 7.13 (t, J = 1.00 Hz, 1 H) 
3-(methylamino)phenol 48b Yield 48 % 1H NMR (400 MHz, CDCl3-d ): δ ppm 2.80 (s, 3 H) 6.07 
- 6.14 (m, 1 H) 6.18 - 6.27 (m, 2 H) 7.04 (t, J=7.96 Hz, 1 H); 13C NMR (100 MHz, CDCl3-d): δ 
ppm 30.91, 99.92, 104.96, 105.85, 130.22, 150.70, 156.85 
 
General Procedure for Syntheisis of Symmetrical and Unsymmetrical Phenoxazinium 
Dyes 49 
A mixture of compounds 44 with 2 mol eq of perchloric acid in i-PrOH (10 ml) was stirred at 30o 
C. A solution of compound 48 in 90% i-PrOH (10 ml) was added dropwise to the above mixture 
during 45 min. The reaction was monitored via UV-Vis.The dark blue solution was evaporated 
and the residue was purified by column chromatography with silica gel, eluting by 
CHCl3/Acetone from 10:1 to 1:1 (v/v) and the dark blue solution was evaporated. To a solution 
of the residue EtOH or MeOH (2 mL), was added AcOEt (20 mL). After ultrasonication for 10 
min, the mixture was filtrated. The powder was washed by AcOEt and Et2O then dried in vacu-
um. 
 
N-(7-(dimethylamino)-3H-phenoxazin-3-ylidene)-N-methylmethanaminium chloride 49a 
Yield 35 % 1H NMR (400 MHz, METHANOL-d4) δ ppm 3.42 (s, 12 H), 6.90 (s, 2 H), 7.37 (d, 
J=7.07 Hz, 2 H), 7.72 (br. s., 2 H); 13C NMR (100 MHz, METHANOL-d4) δ ppm 40.40, 96.12, 
117.18, 133.76, 148.92, 157.90 
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(Z)-N-(7-(dimethylamino)-2-methyl-3H-phenoxazin-3-ylidene)methanaminium perchlorate 
49b Yield 7 %1H NMR (400 MHz, DMSO-d6) δ ppm 2.26 (s, 3 H) 3.10 (br. s., 3 H) 3.33 (s, 6 H) 
6.74 (s, 1 H) 6.84 (d, J=1.77 Hz, 1 H) 7.32 (dd, J=9.47, 1.89 Hz, 1 H) 7.56 (s, 1 H) 7.73 (d, 
J=9.35 Hz, 1 H)13C NMR (100 MHz, DMSO-d6): δ ppm 31.15, 31.49, 41.52, 94.32, 96.40, 
117.41, 129.60, 132.35, 133.13, 133.55, 134.76, 148.38, 149.00, 156.89, 158.52 
 
N-methyl-N-(2-methyl-7-(methylamino)-3H-phenoxazin-3-ylidene)methanaminium per-
chlorate 49c Yield 38 %1H NMR (400 MHz, DMSO-d6) δ ppm 2.52 (s, 3 H) 3.11 (d, J=4.29 Hz, 
3 H) 3.30 (s, 6 H) 6.82 (br. s., 1 H) 6.94 (s, 1 H) 7.13 - 7.26 (m, 1 H) 7.67 (br. s., 2 H); 13C NMR 
(100 MHz, DMSO-d6): δ ppm 22.24, 31.16, 44.33, 94.31, 100.53, 122.50, 130.35¸133.39, 
133.99, 135.06, 136.66, 146.73, 150.56, 159.86, 160.32 
 
(Z)-N-(7-(dimethylamino)-2-methyl-3H-phenoxazin-3-ylidene)ethanaminium perchlorate 
49d Yield 30% 1H NMR (400 MHz, DMSO-d6) δ ppm 1.27 (t, J = 12.8, 4 H), 2.30 (s,3 H), 3.28 
(s, 6 H), 3.50 (q, J=5.81 Hz, 2 H) 6.69 (br. s., 2 H) 7.21 (d, J=9.09 Hz, 1 H) 7.42 (br. s., 1 H) 
7.59 (d, J=9.09 Hz, 1 H); 13C NMR (100 MHz, DMSO-d6): δ ppm 13.86, 17.42, 39.02, 41.15, 
93.87, 95.96, 116.93, 129.33, 132.21, 132.64, 133.17, 134.19, 147.82, 148.52, 156.44, 157.25 
 
(Z)-N-(7-(butylamino)-2,8-dimethyl-3H-phenoxazin-3-ylidene)ethanaminium perchlorate 
50a Yield 43% 1H NMR (400 MHz, Acetone) δ ppm 0.98 (t, J=7.33 Hz, 3 H) 1.39 (t, J=7.20 Hz, 
4 H) 1.44 - 1.57 (m, 2 H) 1.79 (t, J=7.33 Hz, 2 H) 2.40 (br. s., 6 H) 3.61 - 3.77 (m, 4 H) 6.92 (s, 2 
H) 7.64 (br. s., 2 H);13C NMR (100 MHz, acetone-d6): δ ppm 13.15, 13.19, 16.58,30.44, 38.92, 
39.06, 43.85, 43.99, 93.54, 93.59, 93.67, 93.72, 129.07, 129.12, 129.17, 132.40, 134.08, 
134.13, 148.89, 157.05, 157.14, 157.23, 157.32 
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6 APPENDICES 
6.1 Appendix A  
Chapter 1: 1HNMR, 13CNMR, and HRMS Spectra: 
1H NMR and 13C NMR spectra were recorded on a Bruker Avance (400 MHz) spectrometer andhigh-resolution accurate 
mass spectra (HRMS) were obtained either at the Georgia State University Mass Spectrometry Facility using a Waters Q-
TOF micro ESIQ-TOF) mass spectrometer or utilizing a Waters Micromass LCT TOF ES+ PremierMass Spectrometer. 
  
    82 
 
    83 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
    84 
  
 
0
20
40
60
80
100
120
565 615 665 715 765 815 865
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
  
λ (nm) 
Emission of 27b in 90% Glyercol / 10 % Methonal 
(%v/%v) at 20 µM 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
400 475 550 625 700
A
b
so
rb
an
ce
 
Wavelength (nm) 
Absorbance of 27b in Methanol 
5 μM 
7 μM 
10 μM 
12 μM 
15 μM 
17 μM 
23 μM 
25 μM 
y = 0.03x - 0.0067 
R² = 0.9997 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance in Methanol to determine ε of 27b 
    85 
    
 
 
 
 
  
0
0.1
0.2
0.3
0.4
0.5
0.6
400 450 500 550 600 650 700 750 800
A
b
so
rb
an
ce
 
Wavelength (nm) 
Absorbance for 27b in 90% Glycerol/ 10% Methanol (%v/%v) 
 
5 μM 
7 μM 
10 μM 
12 μM 
15 μM 
19 μM 
y = 0.0262x - 0.0114 
R² = 0.9994 
0
0.1
0.2
0.3
0.4
0.5
0.6
0 5 10 15 20
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance for ε of 19 in 90% Glycerol/ 10% Methanol (%v/%v) 
    86 
  
LO-6-2
Time
0.00 2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00
%
0
100
0.00 2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00
%
0
100
0.00 2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00
%
-100
0
100
0.00 2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00
A
U
0.0
1.0
LO-6-2 3: Diode Array 
Range: 1.1919.97
LO-6-2 2475
An2
0
LO-6-2 ELSD
An1
1.55e6
9.760.03
LO-6-2 1: TOF MS ES+ 
TIC
7.17e4
9.53
6.53 7.29 10.52
LO-6-2
Time
0.00 2.5 5.00 7.5 10.00 12.5 15.00 17.5 20.00 2 .5 25.00 27.5 30.00 32.5 35.00
%
0
100
0.00 2.5 5.00 7.5 10.00 12.5 15.00 17.5 20.00 2 .5 25.00 27.5 30.00 32.5 35.00
%
0
100
0.00 2.5 5.00 7.5 10.00 12.5 15.00 17.5 20.00 2 .5 25.00 27.5 30.00 32.5 35.00
%
-100
0
100
0.00 2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00
A
U
0.0
1.0
LO-6-2 3: Diode Array 
Range: 1.1919.97
LO-6-2 2475
An2
0
LO-6-2 ELSD
An1
1.55e6
9.760.03
LO-6-2 1: TOF MS ES+ 
TIC
7.17e4
9.53
6.53 7.29 10.52
LO-6-2
m/z
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400
%
0
100
LO-6-2 481 (9.534) Cm (474:498) 1: TOF MS ES+ 
6.68e4423.1447
425.7673
427.1121
    87 
    88 
    
    89 
 
  
 
0
20
40
60
80
100
120
565 615 665 715 765 815 865
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
  
λ (nm) 
Emission of 27d in 90% Glyercol / 10 % Methonal 
(%v/%v) at 20 µM 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
400 450 500 550 600 650 700 750
A
b
so
rb
an
ce
 
Wavelength (nm) 
Absorbance of 27d in Methanol 
 
5 μM 
7 μM 
10 μM 
12 μM 
15 μM 
17 μM 
23 μM 
25 μM 
y = 0.0236x + 0.0024 
R² = 0.9967 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance  in Methanol  to determine ε of 27d 
    90 
 
 
 
 
 
 
 
 
 
  
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
400 450 500 550 600 650 700 750
A
b
so
rb
an
ce
 
Wavelength (nm) 
Absorbance of 27d in 90% Glycerol/ 10% Methanol (%v/%v) 
7 μM 
12 μM 
17 μM 
19 μM 
21 μM 
23 μM 
y = 0.0273x + 0.078 
R² = 0.9904 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 5 10 15 20 25
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance for ε of 27d in 90% Glycerol / 10% Methanol (%v/%v) 
    91 
 
 
 
 
 
LO-10-1
Time
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
-100
0
100
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
A
U
0.0
2.0e-1
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
LO-10-1 Sm (Mn, 2x3) 1: TOF MS ES+ 
TIC
6.57e4
Area
10.18
19793
9.79
1837.31
489
10.88
2421 11.48
381
LO-10-1 3: Diode Array 
Range: 3.471e-110.44
LO-10-1 2475
An2
0
LO-10-1 ELSD
An1
1.13e6
10.34
0.97
0.23
2.91 5.15
LO-10-1 1: TOF MS ES+ 
TIC
7.36e4
10.18
9.77
7.31
10.86
11.48
LO-10-1
m/z
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400
%
0
100
LO-10-1 509 (10.175) Cm (503:515) 1: TOF MS ES+ 
2.96e4458.7525
459.2205
459.8780
460.8786
461.2665
    92 
 
    93 
    94 
  
    95 
 
 
0
10
20
30
40
565 615 665 715 765 815 865
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
  
λ (nm) 
Emission of 27c in 90% Glyercol / 10 % Methonal 
(%v/%v) at 20 µM 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
400 450 500 550 600 650 700 750
A
b
so
rb
an
ce
 
Wavelength (nm) 
Absorbance of 27c in Methanol 
5 μM 
7 μM 
12 μM 
15 μM 
19 μM 
21 μM 
23 μM 
25 μM 
y = 0.0236x + 0.0024 
R² = 0.9967 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance  in Methanol  to determine ε of 27c 
    96 
 
 
 
 
 
 
 
 
 
  
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
400 450 500 550 600 650 700 750 800
A
b
so
rb
an
ce
 
Wavelength (nm) 
Absorbance for 27 c in 90% Glycerol/ 10% Methanol (%v/%v) 
7 μM 
10 μM 
19 μM 
21 μM 
25 μM 
y = 0.0313x + 0.001 
R² = 0.9988 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance for ε of 27c in 90% Glycerol/ 10% Methanol (%v/%v) 
    97 
 
 
 
 
    98 
 
    99 
    100 
  
 
 
0
20
40
60
80
100
120
565 615 665 715 765 815 865
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
  
Wavelength (nm) 
Emission of 27e in 90% Glyercol / 10 % Methonal 
(%v/%v) at 20 µM 
0
0.2
0.4
0.6
0.8
1
400 500 600 700
A
b
so
rb
an
ce
 
Wavelength(nm) 
Absorbance for ε of 27e in Methanol 
5
10
15
20
25
y = 0.0334x - 0.0252 
R² = 0.9975 
0
0.2
0.4
0.6
0.8
1
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 
Concentration  (μM) 
Absorbance for ε of 27e Methanol 
 
    101 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
450 500 550 600 650
A
b
so
rb
an
ce
 
Wavelength (nm)  
Absorbance of 27e in 90% Glycerol/ 10% Methanol (%v/%v) 
8 μM 
10 μM 
12 μM 
16 μM 
18 μM 
20 μM 
y = 0.0304x - 0.0319 
R² = 0.9979 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 5 10 15 20 25
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance for ε of 27e in 90% Glycerol/ 10% Methanol (%v/%v) 
    102 
 
 
 
 
    103 
    104 
  
    105 
    106 
 
 
 
 
0
20
40
60
80
100
120
565 665 765 865
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
  
λ (nm) 
Emission of 27f in 90% Glyercol / 10 % Methonal 
(%v/%v) at 20 µM 
0
0.2
0.4
0.6
0.8
1
400 500 600 700
A
b
so
rb
an
ce
 
Wavelength (nm) 
Absorance  of 27f in Methanol 
5 μM 
10 μM 
15 μM 
20 μM 
25 μM 
y = 0.0304x + 0.1004 
R² = 0.9936 
0
0.2
0.4
0.6
0.8
1
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorance of 27f in Methanol 
    107 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
450 500 550 600 650
A
b
so
rb
an
ce
 
Wavelength (nm)  
Absorbance of 27f in 90% Glycerol/ 10% Methanol (%v/%v) 
8 μM 
10 μM 
14 μM 
16 μM 
18 μM 
20 μM 
y = 0.0286x - 0.0373 
R² = 0.9982 
0
0.1
0.2
0.3
0.4
0.5
0.6
0 5 10 15 20 25
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance for ε of 27f in 90% Glycerol/ 10% Methanol (%v/%v) 
    108 
 
    
    109 
 
    110 
 
    111 
 
0
20
40
60
80
100
120
565 615 665 715 765 815 865
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
  
λ (nm) 
Emission of 24 in 90% Glyercol / 10 % Methonal 
(%v/%v) at 20 µM 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
425 525 625
A
b
so
rb
an
ce
 
Concentration (μM) 
 Absorbance for  in24 Methanol 
 
5 μM 
10 μM 
15 μM 
18 μM 
20 μM 
25 μM 
y = 0.0336x - 0.0184 
R² = 0.9957 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance for ε of 24 in Methanol 
    112 
 
 
 
 
 
 
 
 
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
450 500 550 600 650
A
b
so
rb
an
ce
 
Wavelength (nm)  
Absorbance of 24 in 90% Glycerol/ 10% Methanol 
(%v/%v) 
6 μM 
8 μM 
10 μM 
12 μM 
14 μM 
16 μM 
18 μM 
20 μM 
y = 0.0399x - 0.0554 
R² = 0.993 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 5 10 15 20 25
A
b
so
rb
an
ce
 
Concentration (μM) 
Absorbance for ε of 24 in 90% Glycerol/ 10% 
Methanol (%v/%v) 
    113 
 
 
 
 
 
 
 
 
    114 
LO-8-DMSO-HNMR.006.001.1R.ESP
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
3
.1
4
2
.1
0
8
.1
9
3
.1
9
2
.0
2
1
.0
0
1
.0
3
3
.1
1
1
.0
5
3
.0
7
0
.7
2
1
.0
6
2
.0
5
DMSO
Water
8
.3
5
8
.3
3
8
.2
0
8
.1
3
7
.8
9
7
.8
7
7
.8
2
7
.7
5
7
.7
3
7
.7
1
7
.5
9
6
.4
3
5
.7
3
4
.4
6
3
.6
0
1
.9
0
1
.8
7
1
.8
5
1
.4
8
1
.4
6
1
.4
4
1
.4
2
0
.9
7
0
.9
5
0
.9
3
-0
.0
2
    115 
LO-8-DMSO-C13.006.001.1R.ESP
220 200 180 160 140 120 100 80 60 40 20 0 -20
Chemical Shift (ppm)
1
8
1
.0
7
1
5
6
.4
7
1
4
1
.3
0
1
4
0
.8
0
1
3
3
.6
5
1
3
2
.0
8
1
3
0
.2
7
1
3
0
.1
9
1
2
9
.7
9
1
2
9
.2
8
1
2
7
.7
0
1
2
2
.9
8
1
1
3
.0
7
1
1
0
.4
4
8
2
.9
2
5
4
.9
4
5
3
.1
6
4
3
.7
5
4
0
.1
4
3
9
.9
3
3
9
.7
2
3
9
.5
1
3
9
.3
1
3
9
.1
0
3
8
.8
8
2
9
.7
7
2
5
.1
9
1
9
.6
6
1
3
.7
5
    116 
y = 25337x + 0.1408 
R² = 0.9966 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0 0.000005 0.00001 0.000015 0.00002 0.000025 0.00003
A
b
so
rb
an
ce
 
Concentration 
-0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
400 450 500 550 600 650 700 750
A
b
so
rb
an
ce
 
Wavelength (nm) 
25
20
15
12
10
5
17
7
    117 
LO-5-DMSO-HNMR.001.001.1R.ESP
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
3
.1
9
0
.9
4
2
.2
6
6
.1
0
2
.1
4
2
.9
7
2
.0
1
1
.0
0
0
.9
1
2
.1
1
4
.2
0
2
.0
0
1
.0
1
DMSOWater
8
.3
8
8
.3
6
7
.9
2
7
.8
2
7
.7
7
7
.7
5
7
.7
3
7
.7
1
7
.5
9
7
.5
6
7
.4
4
6
.3
1
5
.7
5
4
.4
6
3
.4
7
1
.8
8
1
.8
6
1
.8
5
1
.6
5
1
.4
7
1
.4
5
1
.4
4
1
.1
7
0
.9
7
0
.9
5
0
.9
3
    118 
LO-5-DMSO-C13.004.001.1R.ESP
220 200 180 160 140 120 100 80 60 40 20 0 -20
Chemical Shift (ppm)
1
7
9
.4
1
1
5
6
.8
0
1
4
3
.8
0
1
4
0
.4
9
1
4
0
.0
1
1
3
2
.4
3
1
3
0
.0
8
1
2
9
.0
5
1
2
8
.4
6
1
2
6
.2
9
1
2
3
.1
3
1
2
2
.6
3
1
1
3
.2
4
1
1
0
.7
8
8
2
.7
8
5
1
.3
2
4
3
.6
8
4
0
.0
4
3
9
.8
4
3
9
.6
3
3
9
.4
2
3
9
.2
1
3
9
.0
0
3
8
.7
9
2
9
.6
2
2
5
.4
7
1
9
.4
6
1
3
.5
6
    119 
 
y = 33343x + 0.0674 
R² = 0.9945 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.000005 0.00001 0.000015 0.00002 0.000025 0.00003
A
b
so
rb
an
ce
 
Concentration 
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
400 500 600 700
A
b
so
rb
an
ce
 
Wavelength (nm) 
4
5
7
10
12
    120 
ESS_69H.ESP
11 10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
3
.2
0
2
.1
3
2
.1
1
3
.2
3
2
.2
3
1
.0
0
1
.0
2
2
.1
1
2
.1
4
1
.1
1
1
.0
5
1
.0
1
1
.0
7
1
.0
2
DMSOWater
9
.2
5
9
.2
3
8
.3
3
8
.3
1
8
.1
9
8
.0
3
7
.8
9
7
.7
9
7
.7
7
7
.6
8
7
.6
3
7
.5
6
6
.4
7
4
.3
9
4
.3
7
4
.3
5
4
.1
6
1
.8
5
1
.8
3
1
.8
1
1
.7
9
1
.4
9
1
.4
7
1
.4
5
1
.4
3
0
.9
8
0
.9
6
0
.9
4
    121 
ESS-69.ESP
220 200 180 160 140 120 100 80 60 40 20 0 -20
Chemical Shift (ppm)
1
6
1
.4
0
1
4
6
.2
4
1
3
2
.3
3
1
3
1
.2
6
1
2
9
.8
4
1
2
9
.1
7
1
2
9
.0
9
1
2
6
.6
5
1
2
5
.9
9
1
2
2
.3
6
1
1
2
.0
1
1
1
1
.7
4
1
0
9
.4
9
7
4
.9
1
4
3
.0
9
4
0
.0
4
3
9
.8
4
3
9
.6
3
3
9
.4
1
3
9
.2
1
3
9
.0
0
3
8
.7
9
3
1
.4
1
2
9
.6
6
1
9
.4
9
1
3
.6
9
-0
.0
1
    122 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
400 500 600 700
A
b
so
rb
an
ce
 
Wavelength (nm) 
y = 32333x - 0.0078 
R² = 0.9962 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 0.000005 0.00001 0.000015 0.00002 0.000025
A
b
so
rb
an
ce
 
Concentration 
    123 
ESS_70.004.001.1R.ESP
11 10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
3
.1
1
2
.0
7
2
.0
7
2
.0
3
1
.0
0
2
.8
9
0
.9
9
2
.0
0
1
.0
3
0
.9
8
1
.0
3
0
.9
8
DMSO
Water
9
.1
8
9
.1
6
8
.3
9
8
.0
4
7
.8
7
7
.8
6
7
.8
5
7
.7
3
7
.6
5
7
.6
4
7
.6
4
7
.6
2
6
.1
5
4
.4
8
4
.0
5
    124 
ESS_70.006.001.1r.esp
200 180 160 140 120 100 80 60 40 20 0
Chemical Shift (ppm)
1
6
1
.9
9
1
5
5
.5
5
1
4
6
.8
3
1
3
2
.9
1
1
3
1
.8
4
1
3
0
.4
4
1
3
0
.2
6
1
2
9
.7
4
1
2
9
.6
8
1
2
7
.2
3
1
2
6
.5
8
1
2
2
.9
4
1
1
2
.6
0
1
1
2
.3
3
1
1
0
.0
7
7
5
.5
1
4
3
.6
6
4
0
.6
0
4
0
.3
9
4
0
.1
9
3
9
.9
8
3
9
.7
6
3
9
.5
6
3
9
.3
5
3
1
.9
9
3
0
.2
4
2
0
.0
7
1
4
.2
8
 
    125 
 
  
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
400 450 500 550 600 650
A
b
so
rb
ac
n
e
 
Wavelength 
5
7
10
12
15
17
20
25
30
y = 37660x + 0.1161 
R² = 0.9955 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 0.00001 0.00002 0.00003 0.00004
A
b
so
rb
an
ce
 
Concentration 
    126 
 
6.2 Appendix B 
Chapter 2: 1HNMR, 13CNMR, and HRMS Spectra: 
1H NMR and 13C NMR spectra were recorded on a Bruker Avance (400 MHz) spectrometer. 
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ES_41_1H_DMSO.002.001.1r.esp
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ESS_15_H1_CDCl3.001.001.1r.esp
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ESS_3_1H_DMSO.001.001.1r.esp
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ESS-46-dye.001.001.1r.esp
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Chemical Shift (ppm)
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y = 0.0371x + 0.0105 
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6.3 Appendix C 
Chapter 3: 1HNMR, 13CNMR, and HRMS Spectra: 
1H NMR and 13C NMR spectra were recorded on a Bruker Avance (400 MHz) spectrometer. 
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